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Single ventricle (SV) anomalies account for one-fourth of all cases of congenital Heart 
disease. The conventional second and third stage i.e. Comprehensive stage II and Fontan 
procedure of the existing three-staged surgical approach serving as a palliative treatment 
for this anomaly, entails multiple complications and achieves a survival rate of 50%. 
Hence, to reduce the morbidity and mortality rate associated with the second and third 
stages of the existing palliative procedure, the novel alternative techniques called “Hybrid 
Comprehensive Stage II” (HCSII), and a “Self-powered Fontan circulation” have been 
proposed. The goal of this research is to conduct in-vitro investigations to validate 
computational and clinical findings on these proposed novel surgical techniques. The 
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In human anatomy, the cardiovascular system comprises the heart and the system of vessels 
that include the arteries, veins, and capillaries. The heart plays a vital role in the circulatory 
system. The heart's main function is to pump the continuous flow of blood throughout the 
body's circulatory system. The circulatory system consists of systemic and pulmonary 
circulations. In the systemic circulation, the heart pumps oxygenated blood to the body 
through arteries, and the deoxygenated blood gets transported back to the heart through 
veins. In the pulmonary circulation, blood is transported between the heart and lungs to 
exchange carbon dioxide with oxygen during the respiration process. The heart comprises 
four chambers. The two lower chambers are ventricles, and the two upper chambers are 
atria. Two ventricles (left and right) are separated by a wall called the interventricular 
septum. Two atria (left and right) are separated by a wall called the interatrial septum. The 
deoxygenated blood from the systemic circulation returns to the heart's right atrium through 
two large veins. The blood from the lower systemic circulation returns through the inferior 
vena cava (IVC), and the upper systemic circulation returns through the superior vena cava 
(SVC). The deoxygenated blood from the myocardium returns to the right atrium through 
the coronary sinus.  
The deoxygenrated blood flows through the tricuspid valve from the atrium to the ventricle 
during atrial contraction in the right heart. When the right ventricle contracts, the tricuspid 
valve closes, and the blood flows through the pulmonary valve into the pulmonary trunk. 
The pulmonary trunk is bifurcated into left and right pulmonary arteries to flow the blood 




The oxygenated blood returns from the lungs to the left atrium through pulmonary veins in 
the left heart. Then the blood is pumped from the left atrium to the left ventricle through 
the mitral valve and finally into the aorta through the aortic valve for systemic circulation.  
Figure 1 depicts the human circulatory system. 
 





The human heart functions in a cardiac cycle. The cardiac cycle consists of four major 
stages :  
1. Isovolumic relaxation  
2. Inflow,  
3. Isovolumic contraction  
4. Ejection 
The Wiggers diagram shows these four significant stages during a cardiac cycle [2], as 
shown in Figure 2. Stages of  “Isovolumic relaxation” and “Inflow” comprise the atrial 
“Systole” and the ventricular "Diastole" period. In this period, blood returns into the 
relaxed ventricle of the heart by flowing through the atria. Notably, towards the end of the 
"Diastole," the atria contract and pump blood into the ventricles. This pressurized blood 
flow from atria to ventricles during the ventricular diastole period is called the atrial systole 
(“atrial kick”).  Stages of  “Isovolumic contraction” and “Ejection” comprise the 
ventricular “Systole” period. In this period, simultaneous pumping of both ventricles 
occurs to push blood to the pulmonary trunk and aorta. 
1.1. Blood Flow  
In the circulatory system, the blood flow is primarily considered as laminar in major 
conduits and turbulent in specific regions. Typically, a healthy adult's average cardiac 
output (CO) is around 5-6 
min
L at a resting condition [3]. In a vessel, the blood flow is 
related to the difference in pressure and the resistance (R) in that vessel. Blood flow occurs 











CO is defined as the amount of blood pumped out by the left ventricle per minute. This is 
a product of heart rate and stroke volume. 
 
Figure 2 Wiggers Diagram for Cardiac Cycle [2] 
 
1.2 Blood Pressure  
Blood pressure is an essential hemodynamic parameter in the cardiovascular system. 
Typically for normal physiology, the peak systolic and diastolic aortic pressures are 120 




“pulse pressure”. The compliance level and stroke volume dictate the pulse pressure. The 
pulse pressure increases based on the increase in the stroke volume and decrease in vascular 
compliance. The pressure decreases if the stroke volume decreases and vascular 
compliance increases.  
Mean Arterial Pressure (MAP) is defined as the average aortic pressure over one cardiac 
cycle. This pressure is lower than the average systolic (30% of the cardiac cycle) and 
diastolic (70% of the cardiac cycle) pressures. MAP can be computed by multiplying the 
CO and systemic vascular resistance and summing with central venous pressure. Figure 3 
shows the mean pressure and the percentage of total CO present in major vessels of the 
cardiovascular system. 
 




1.3. Frank-Starling Law  
This law states that the heart has an intrinsic capability of increasing its contraction force 
and the corresponding stroke volume due to an increase in the end-diastolic volume (EDV) 
[5]. Deconstructing the law, the heart works harder to increase CO to synchronize with the 
venous return. To satisfy the law of conservation of mass in the circulatory system, what 
goes into each ventricle must come out. Due to this mechanism, as a larger blood volume 
flows into the ventricle, the cardiac muscle gets stretched and increases in contraction 
force. Figure 4 shows that the EDV increases as more blood is pumped into the ventricle. 
This increases the force of contraction and increases stroke volume to maintain a constant 
end-systolic volume (ESV). 
 
Figure 4 Frank-Starling mechanism [5] 
1.4. Single ventricular disease 
Congenital Heart Diseases or defects (CHD) are the problems with the heart's structure that 
are present at birth. There are various types of CHD [6]. Single ventricle (SV) anomalies 




falls under the category of SV anomalies. Untreated, the anomaly is uniformly fatal. 
Despite surgical and pharmaceutical advances for the treatment of SV anomaly, this 
anomaly remains the significant cause of morbidity and mortality in the pediatric CHD 
population.    
A single ventricle is a defect in the heart where one ventricle of the heart is malformed. As 
a result, the heart has one pumping chamber. This causes the oxygenated blood to mix with 
the deoxygenated blood, thereby reducing the amount of oxygenated blood getting to the 
systemic circulation. As a result of this abnormal circulation, various symptoms like 
cyanosis (blue or purple tint to the skin), difficulty in breathing and feeding, and lethargy 
can be seen in this subset of patients. 
Single ventricle defects are classified into  
 Hypoplastic left heart syndrome (HLHS) 
 Pulmonary atresia 
 Tricuspid Atresia 
 Univentricular heart  
1.4.1. Hypoplastic left heart syndrome 
Hypoplastic left heart syndrome (HLHS) is a congenital heart condition where the left 
ventricle, mitral and aortic valves, and aorta are underdeveloped and unable to function. 
Lev initially coined this in 1952 as hypoplasia of the aortic tract complex [7]. Figure 5 
shows the comparison between normal heart anatomy and HLHS heart anatomy. In HLHS, 




Two options exist to treat HLHS: a series of staged palliations using a single ventricle 
strategy [8], [9] or primary cardiac transplantation. The transplantation procedure is limited 
due to the availability of infant organs, the limited lifespan of the organ, and the need for 
continued anti-rejection therapy. The surgical technique depends on the patient's 
physiological condition and the institution's surgical planning. The mortality rate remains 
high even after treatment. A three-stage palliative procedure was developed to improve the 
survival rate. 
 
Figure 5 Anatomy of Normal heart (L) and HLHS heart (R) (The Children's Hospital of 
Philadelphia, n.d) 
 
1.4.2. Three-stage palliative procedure  
In the last few decades, different strategies were implemented to treat HLHS. The three-
staged palliative procedure was developed to convert the parallel circulation to series 
circulation with one ventricle and bypass the underdeveloped chamber. Deoxygenated 




 Stage 1: Norwood Procedure 
In this stage, atrial septectomy is performed. Then hypoplastic aorta is reconstructed and 
connected to the right ventricle in place of the pulmonary root. A Blalock Taussig (BT) 
shunt is implanted between the innominate artery and the pulmonary arteries to create a 
parallel path between the systemic circulation and the pulmonary circulation. The 
Norwood procedure is performed very shortly after birth [10], [11]. 
 
 
Figure 6. HLHS circulation before three staged procedure (L) and rectified circulation after three 
staged procedure (R) 
 Stage 2: Glenn Procedure 
In this stage, SVC is disconnected from the right atrium and connected directly to the right 
pulmonary artery, and the BT shunt is disconnected. The primary purpose of this surgery 
is to send the deoxygenated blood flow from the upper systemic circulation to the 
pulmonary circulation. The Glenn procedure is performed between three and six months 




 Stage 3: Fontan Procedure 
IVC is disconnected from the right atrium in this stage and connected directly to the pulmonary 
arteries for a Total Cavopulmonary Connection (TCPC). This surgery results in total passive 
drainage of the caval blood flow to the pulmonary circulation, relieving the single ventricle from 
pumping blood to the pulmonary circulation. The atrial septal defect is closed. The Fontan 
procedure is performed around six months to a year after the second stage.    
1.5. Significance of Study 
Though the three-staged palliative procedure is established as the most viable option to 
treat this HLHS anomaly but this three-staged procedure is still flawed. The research topic 
is at the interface of the engineering and pediatric congenital heart disease domain. It 
combines in-vitro modeling techniques to analyze the hemodynamics of two novel 
alternative palliative procedures for single ventricular disease.  
This study will elucidate the various in-vitro modeling techniques used to investigate the 
hemodynamics and efficacy of the following alternative surgical techniques:  
 In-vitro validation of Hybrid Comprehensive stage II (HCSII) circulation  
 In-vitro validation of self-powered Fontan circulation  
The outcome of these studies can significantly contribute to the positive outcome of patient 
care and provide additional insight into the hemodynamics of these palliative procedures.  
1.6. Problem Statement – 1 
The existing three staged palliative procedure for the single ventricular anomaly entails 
multiple complications and achieves a survival rate of 50%. To reduce the trauma 
associated with the second stage of the existing procedure, a novel alternative surgical 




collaborators in Arnold Palmer children’s hospital. This palliative procedure can be an 
alternative for a select subset of SV patients with the adequate antegrade aortic flow. The 
procedure reduces surgical trauma in patients by introducing a stented intrapulmonary 
baffle to avoid dissection of the pulmonary arteries and reconstruction of the aortic arch 
while obviating the dissection of the distal arch and ductal continuation. 
The goal of this study is to validate in-silico results relative to stented baffle deformation 
and particle tracking. This in-vitro model is tuned to match the catheter data and then used 
to verify whether pulmonary arteries are obstructed due to systemic pressure loads and 
track particles to identify the potential pathological flow fields and the possibility of 
thrombus formation. 
1.7. Problem Statement -2 
Although the Fontan circulation has been successfully established as the final stage in the 
palliative procedure for treating HLHS but can lead to failures. The major reason for 
failures comprise  
 High pressure in IVC  
 High Pulmonary vascular resistance  (PVR) 
 Ventricular dysfunction 
These reasons can lead to a multitude of diseases. Many techniques to improve the failing 
Fontan circulation have been proposed over decades. These techniques involve improving 
geometrical parameters of total cavopulmonary connection (TCPC) and active powering 
of Fontan circulation. But most of the proposed ideas involved issues. These issues include 





A novel, innovative, rapidly testable alternative is proposed to achieve the same endpoints 
as a synthetic pump in the Fontan circulation. Through this procedure, the reserve 
mechanical energy of the heart itself is tapped to “assist” the Fontan circulation by creating 
a novel bifurcation graft, henceforth called the Injection Jet Shunt (IJS), seen in Figure 7. 
A new, technically straightforward surgical operation is proposed in which this graft, 
originating from either the ventricle or aorta, bifurcates with each tapered distal limb 
sutured into the pulmonary arteries (PA) in such a way that flow is directed parallel to each 
PA and the energy and momentum of this flow is efficiently transferred. The hypothesis is 
as follows: The inclusion of an IJS of suitable geometry into the “failing Fontan” 
circulation can (1) decrease IVC pressure and (2) increase systemic oxygen delivery while 
limiting the obligatory left-to-right shunt through the graft to a clinically acceptable value. 
The approach challenges the existing paradigm that a synthetic pump is required to assist 
the Fontan circulation. It addresses the critical barriers to progress in this field by offering 
an alternative, effective palliation for the failing Fontan while delaying or circumventing 
the need for heart transplantation and implantation of synthetic pumps with their well-
known complications.  
 




This study aims to validate the Computational Fluid Dynamics (CFD) results and 
characterize the jet flow field in the Fontan circulation. Increased inferior vena cava 
pressure has been identified as a clinically significant parameter for Fontan failure. The in-
vitro model helps to elucidate the relevant hemodynamics that can lead to optimal 
implementation of an injection jet to reduce the pressure in the inferior cava.  
1.8. Limitations and Assumptions 
In-vitro efforts have seen the implementation of lumped parameter models of the peripheral 
circulation as well as the region of interest. To simplify the modeling, the lumped 
parameter has been reduced to four compartments, i.e., upper and lower systemic 
circulations and left and right pulmonary circulations. In the lumped parameter model, the 
inertance effect is not replicated. Moreover, the region of interest in  Mock Flow Loop 
(MFL) has been assumed to be rigid. The blood model used in MFL studies is assumed to 
be Newtonian.  
1.9. Definition of terms  
A   Area of the conduit 
V

  Average velocity of the fluid  
C   Compliance 
L   Containment limit  
p   Containment probability  
ca   Critical crack growth 
K   Cyclic stress intensity factor   




fallt   Fall time 
.
entQ   Flow entrainment rate  
Q   Flowrate 
g  Gravitational  constant 
h   Head loss in fluid  
hoop   Hoop stress 
iL   Inertance 
   Infinite-shear viscosity 
ia   Initial crack growth 
IJSQ   Injection jet shunt flow 
1    Inverse normal distribution 
relt   Jet relaxation time 
L   Length of the conduit/Inductance 
K   Loss coefficient  
IVCQ   Lower body blood flowrate 
lowerC   Lower compliance  
   Mean 
N   Number of cycles to failure  
P   Pressure 




1   Principal stress 
pQ   Pulmonary flow 
r   radius of conduit 
da
dN
  Rate of crack growth  
   Relaxation time constant 
R   Resistance 
riset   Rise time 
   Shear rate 
   Standard deviation 
x   Strain in x-direction 
y   Strain in y-direction 
x   Stress in x-direction 
y   Stress in y-direction 
sQ   Systemic flow 
2o
Ca   Systemic oxygen concentration 
2SVCo
C   Systemic venous concentration 
SVCQ   Upper body flowrate 
   Viscosity 
v   Von-misses stress 




E   Young’s modulus 
0   Zero-shear viscosity 
1.10. List of Acronyms 
ABS  Acrylonitrile butadiene styrene 
ABG  Assisted bi-directional Glenn  
APC  Atriopulmonary connection 
BDG  Bidirectional Glenn 
BSA  Body surface area 
CO  Cardiac output 
CPB  Cardiopulmonary bypass 
CVP  Central venous pressure   
CFD  Computational Fluid Dynamics  
CAD  Computer Aided Design 
CHD  Congenital Heart Diseases 
DHCA  Deep hypothermic circulatory arrest 
EDV  End-diastolic volume 
ESV  End-systolic volume 
HCSII  Hybrid comprehensive stage II 
ICPC  Inferior cavopulmonary connection 
IVC  Inferior vena cava 
IJS  Injection jet shunt 
LCA  Left carotid artery 




LSA  Left subclavian artery 
LPM  Lumped parameter model 
MRI  Magnetic resonance imaging 
MPA  Main pulmonary pressure 
MAP  Mean arterial pressure 
MFL  Mock flow loop 
PRT  Particle residence time 
PTFE  Polytetrafluoroethylene 
PA  Pulmonary arteries 
PVR  Pulmonary vascular resistance 
RCA  Right carotid artery 
RPA  Right pulmonary artery 
RSA  Right subclavian artery 
RV  Right ventricle  
SV  Single ventricle 
SVC  Superior vena cava 
SVR  Systemic vascular resistance 
TCPC  Total cavopulmonary connection 
VVC  Veno-venous collateral vessel 
VAD  Ventricular assist device 




2. Review of the Relevant Literature 
2.1.1. Stage 1: Norwood Surgical Procedure  
 
Figure 8  Norwood with mBT shunt 
Figure 8 represents the stage I Norwood surgery. The primary aim of this surgical 
procedure is to provide an unrestrictive systemic blood flow while balancing the pulmonary 
flow, i.e., the /p sQ Q ratio. To achieve this physiology, a neo-aorta is constructed using the 
autologous aorta and pulmonary artery, followed by placing a shunt in the pulmonary 
artery. Depending on the patient’s condition, an alternative procedure is to band the 
pulmonary artery and stent the descending aorta. The mixing of oxygenated and 
deoxygenated blood occurs due to the doubling of volumetric load on the single ventricle. 
The diameter of the shunt is designed to provide a balanced pulmonary flow with the 
systemic flow. Figure 9 highlights the outcome of creating parallel pulmonary and systemic 
circulation. Pulmonary Vascular Resistance (PVR) and Systemic Vascular Resistance 




relative resistance from the PVR and SVR determines the distribution of blood to the 
systemic and pulmonary as the single ventricle supplies the blood. 
 
Figure 9 Normal circulation (L) and stage 1 reconstructed (R) parallel pulmonary and systemic 
circulation. LV= left ventricle, RV= right ventricle, SC= systemic circulation, PC= pulmonary 
circulation, SPAS= systemic to pulmonary artery shunt  
In 1945 Blalock and Taussig [13] [13] developed a shunt to treat tetralogy of Fallot. The 
original procedure proposed was to connect the cut end of the subclavian artery or carotid 
artery to the pulmonary artery. The main disadvantage of BT shunt includes phrenic nerve 
injury and operative dissection time. In addition, some of the blood supply to the upper 
body is interrupted due to the occluded artery [14].[14].  To overcome the disadvantage of 
BT shunt, a modified BT shunt (mBT shunt) was developed, which involves the 
introduction of polytetrafluoroethylene (PTFE) as a biomaterial. The mBT shunt is placed 
in between the pulmonary artery and subclavian or carotid artery. Diastolic runoff and high 
pulse pressure are characteristics of mBT shunt physiology. As a result, diastolic coronary 
circulation is reduced, thereby giving rise to myocardial ischemia and circulatory 
instability, leading to the patient's death [15][15]. 
In 1961 central shunt or Waterson shunt (WS) was reported to treat the tetralogy of Fallout. 
A conduit is installed between the pulmonary artery and ascending aorta, giving a balanced 




for neonates having a small subclavian artery. The Sano shunt or right ventricle shunt is a 
variation where a conduit is inserted between the pulmonary artery and the right ventricle 
.[16]. As the Sano shunt is larger in diameter, less diastolic pressure runoff is possible due 
to a more pulsatile pulmonary blood flow and less pulsatile systemic flow. 
Bilateral Pulmonary Artery banding (bPAB) is an alternative option for the Stage I 
procedure. The aim of bPAB is to reduce the excess pulmonary blood flow and pulmonary 
artery pressure. A band is installed around one or both sides of the pulmonary artery, 
thereby reducing the blood flow in the lungs, which prevents the pulmonary over 
circulation that regulates the /p sQ Q . Resistance at the banded location is sensitive to the 
band’s tightness; it is difficult to achieve the optimal tightness followed by the desired 
balance of pressure and flows, making it bPaB’s limitation. This technique is useful when 
the ductus arteriosus is kept patent or there is a sufficient section of the native aorta is 
present to provide systemic circulation. 
In Sano et al. [16][16] study, improvement was seen in short and long-term RVS patient 
survival compared to mBT patients. RVS eliminated the diastolic runoff, and hence the 
diastolic pressure was restored, ventricular work reduced, and systolic hypertension was 
relieved. Sano et al.'s [16]Sano et al.'s [16]  study were successful as hemodynamic 
instabilities did not occur in patients, and it was successful with low-weight patients. There 
was an increase in the transconduit pressure, and diastolic reverse flow decreased months 
after the procedure. Keeping a transplant-free 12 months as a criterion, a clinical study was 
conducted at 15 centers across the USA; based on a sample of RVS and mBT shunts, 
patients with RVS shunts were healthier compared to the patients with mBT shunt. A study 




mBT shunt. A sample size showed that more interventions were required with Sano shunt 
as complications included cerebral embolic, cardiopulmonary resuscitation, and femoral or 
subclavian veins closure.  
Different shunts have been developed to overcome the drawbacks associated with the BT 
and mBT shunts. Changes to physiological conditions make Norwood's procedure difficult. 
As the lungs of a neonate develop, the PVR decreases significantly, which results in 
increased pulmonary flow rate and decreases systemic flow rate, thereby causing an 
unbalanced /p sQ Q . Placement of shunt and surgical anastomosis design influences the 
final surgical results. In addition, a variety of native aortic arch morphologies and 
coarctations exist. They range from tubular, dilated, and typical for native arch and 
localized for coarctation.  
2.1.2. Stage 2: Bi-direction Glenn and Comprehensive Stage II Surgical 
Procedure 
 




Two different processes usually perform the stage II surgical procedure. Figure 10 
represents the Bidirectional Glenn (BDG) surgical procedure. This procedure is performed 
during six to eight months of age. The surgical procedure aims to lower the load on the 
right ventricle and provide a low-pressure pulmonary flow. The BDG procedure involves 
removing mBT shunt and dissection of SVC from the right atrium and anastomosed to 
Right Pulmonary Artery (RPA). The deoxygenated blood from the upper body returns to 
the lungs.   The Norwood procedure has been the option to achieve the stage I palliation 
aim for the past twenty years [17], [18]..[17], [18]. Early mortality remains as high as 20-
30% after the palliation despite significant improvement in survival [19], [20] [21], [22], 
[23]. [19], [20], [21], [22], [23]. This procedure avoids cardiopulmonary bypass (CPB), 
deep hypothermic circulatory arrest (DHCA), and cardiac arrest.  The potential 
disadvantages of the hybrid procedure include malperfusion, which arises due to the 
retrograde aortic arch obstruction and mechanical distortion of the branch PAs. Due to the 
learning curve of the new technology, high morbidity and mortality were reported [21], 
[22], [24]. [21], [22], [24]. This places a greater surgical requirement on the comprehensive 
stage II palliation.  
 




Akintuerk et al. [23] [23] reported success in the comprehensive stage II procedure, an 
alternative surgical procedure to BDG. The surgical technique is considered complex and 
is conducted during 4-6 months of age. As shown in Figure 11, the comprehensive stage II 
involves the patent ductus arteriosus stent removal followed by the bands on pulmonary 
arteries. Following this, the aortic arch reconstruction occurs, followed by atrial 
septectomy and bidirectional cavopulmonary anastomosis creation. This procedure also 
involves the creation of the Damus-Kaye Stansel connection. Same physiology is 
established between comprehensive stage II and Bi-directional Glenn procedure.  
Gibbs et al. [26] [26] proposed and reported various results when comparing the hybrid 
procedure to Norwood. The combined surgical and interventional technique is an alternate 
to stage I palliation. Ruiz et al. [27] [27] reported a patient undergoing a heart transplant 
after ductal stenting. Mitchell et al. [28] [28] reported the PA banding as a bridge to 
transplantation to prevent irreversible pulmonary vascular disease. Galantowicz et al. [22] 
[29] [22], [29] pioneered and popularized the hybrid approach and intended to use this 
approach on neonates with HLHS conditions.No difference in PA pressure existed between 
Norwood and hybrid during the pre-stage II hemodynamics. No difference between arterial 
saturation /p sQ Q . Both groups had equivalent parameters during the pre-stage II 
evaluation.  
The crucial cause of failure in staged palliation for HLHS is progressive systemic 
ventricular dysfunction. The mechanism of failure for the right ventricular may be related 
to the myocardial damage during the Norwood procedure with cardiac arrest DHCA, high 
afterload on the right ventricle, and volume overload, which occurs due to the systemic-




dysfunction is one of the primary indicators for a heart transplant. Patients who completed 
the pre-stage II palliation, a patient, had atrioventricular valve insufficiency. The 
atrioventricular valve was corrected by valve repair during stage II palliation. Norwood 
group had patients with mild ventricular dysfunction and patients with a severe condition 
requiring transplantation. Patients had more than a moderate level of atrioventricular valve 
insufficiency, and patients underwent valve repair.  
Progressive ventricular dysfunction was identified during the interim stage on patients that 
underwent hybrid stage I. A Patient required heart transplantation after stage II palliation. 
Another patient had aortic arch perfusion diminished, aortic isthmus obstruction, 
myocardial dysfunction, and minor narrowing of the reverse BT shunt. 
Cardiopulmonary bypass (CPB) is initiated with the arterial cannula placed in the main 
pulmonary artery; this is done after the re-sternotomy procedure. For deep hypothermic 
circulatory arrest (DHCA), the patient is cooled, the branch pulmonary artery bands are 
removed. Atrial septectomy is performed when cardioplegic cardiac arrest is achieved. 
Using a homograft patch, the aortic arch is reconstructed under DHCA condition along 
with regional cerebral perfusion. With the standard technique, a proximal Damus-Kaye-
Stansel anastomosis is achieved. In most patients, an autologous pericardial patch from 
hilum to hilum is used to enlarge the branch PA. The bidirectional cavopulmonary shunt is 
placed with the standard technique while kept on-pump beating state. The final procedure 
involves the closure of the sternum in most patients.  
To facilitate aortic arch reconstruction, retained stented duct tissue is used in origin [30]. 
Upon DHCA, the main PA and the branch PA were transected and resected. The area 




the aortic isthmus. The patch for the aortic arch reconstruction is obtained from the remains 
of the stented ductus. The reconstruction is achieved by sewing the divided native aortic 
arch to the lateral edges of the divided ductus.  
Advantages of using this modification are as follows, the stented material in place as in 
natural transverse aortic arch, the risk of bleeding and recurrent laryngeal nerve injury is 
significantly reduced as there is a continuity between the ductal material and the 
descending aorta. Immunologic sensitization can be avoided as homograft material is not 
used, thereby improving the potentiality of transplantation. Potential disadvantages include 
the development of aneurysmal and recurrent obstruction at the aortic isthmus. 
Honjo and Caldarone [31] concluded the study by mentioning that a conclusion cannot be 
reached on the impact on the ventricular function and type of palliation based on 
preliminary analysis. Hybrid patients appear to have a better ventricular function at the pre-
stage II evaluation. 
2.1.2.1. Morbidity and Mortality 
Recent studies show that there is 80-97% survival after stage I hybrid palliation; during 
such studies, extreme high-risk patients were excluded [23], [29], [32]. [23], [29], [32]. 
Between 2004-2007, a study was conducted on neonates with HLHS and its variants that 
have undergone Norwood and hybrid. No difference in survival was seen between patients 
with or without reverse BT shunts. Neonates died, and additional neonates underwent heart 
transplantation after stage I palliation. Neonates were in the interim death stage after the 
hybrid palliation. 
Clinical and investigations have reported the adoption of systemically derived accessory 




[36]. Van de Wal et al. [33]. [33] studied patients with an average age of 5.6 years, reported 
no influence on survival rate. McElhinney et al. [34] [34] studied patients with an average 
age of 7.8 months, reported higher but statistically insignificant mortality. Mainwaring et 
al. [35] [35] studied patients with an average age of 10 months reported higher mortality. 
2.1.2.2. In-vitro and in-silico approach  
Many researchers have conducted both in-vitro and in-silico simulations to address 
problems that arise postoperatively. Pulmonary artery stenosis is one problem that is seen 
in patient’s post-operative. The venovenous collateral vessel is the second problem seen in 
31-33% of patients who undergo the BDG procedure. To improve the efficacy of the 
procedure, the use of ABG is discussed. Results obtained by researchers show the 
advantages of ABG and how it could potentially reduce the three-stage palliative procedure 
to a two-stage palliative procedure. An in-depth analysis is done of the literature to 
understand the need to improve this surgical technique. To overcome the surgical trauma 
associated with BDG, a novel surgical technique is discussed at the end of the section that 
mentions the procedure and its advantages compared with BDG and comprehensive stage 
II.  
Liancai et al. [37] [37] conducted a study that focused on patients with HLHS and unilateral 
pulmonary artery stenosis after the Glenn procedure. Four three-dimensional Glenn models 
with different left pulmonary artery stenosis rate by diameter were generated 
(0%,25%,50%,75%). The extreme condition was considered to understand the effect of 
stenosis on the flow field, which is the acute artery blockage by 75%.  
A multiscale model was developed along with the lumped parameter model (LPM). Global 




ascending aorta, the descending aorta, and the SVC can be computed [38]. [38]. The LPM 
consisted of six blocks that included the single ventricle heart, left and right lung, the 
ascending aorta, and lower and upper limb vein. The vessels' viscous, compliance, and 
inertia were represented using the Windkessel models that consist of resistors, capacitors, 
and inductors. To simulate the cardiac valves, diodes were used in the circuit. For each 
compartment, the mass and momentum conservation laws were expressed using Qin (t), 
Pin(t), Qout(t), and Pout(t), which represent the instantaneous volumetric flow rate and 
pressure at the inlet and outlet of compartments [39].. [39]. 
The rhythmic contraction E(t) [40], [41], [42] [40], [41], [42] of a single ventricle was 
represented as a function of pressure and volume. E(t) is the elastance function that changes 
with time is represented as mmHg/ml. The elastance is expressed using   vS V t , 
representing the ventricle volume and pressure, and V0 refers to reference volume.  
Boundary conditions were applied to the coupled 0D and the 3D model. Initial conditions 
were imposed on the 3D model, the output obtained at each step was imposed on the 0D 
model. The limitation in this study includes rigid boundary conditions on the walls of the 
3D model, and fluid-structure interaction models were not taken into account. To guarantee 
a convergent solution, five cardiac cycles were simulated. Parameters such as Wall shear 
stress (WSS), total pressure, and flow were recorded every 10-time steps. For this model, 
the boundary conditions set on the 3D model were the pressure on the pulmonary artery 
distal branch and flow rate through the superior vena cava.  
Further to the simulation result, models 2,3 and 4 showed imbalanced pulmonary perfusion 
compared to model 1. Relation between blood flow to the localization of atherosclerosis 




(WSS mechanism). There was a decrease /LPA SVCR when stenosis was above 75%; this 
results in abrupt pressure differences between distal and proximal stenosis. The 
development of the PA tree may be complicated due to the unbalanced lung perfusion [46] 
. [46]. Liancai et al. concluded the study by mentioning that if the stenosis rate above 75% 
may lead to power loss and severely unbalanced blood perfusion into each lung. For the 
patient’s development, this condition must be treated before Glenn.  
Chiara et al. [47] [47] study focused on an eight-month-old patient who underwent bi-
directional Glenn and was diagnosed with a venovenous collateral (VVC) vessel. Clinical 
studies reported 31-33% of patients undergoing the BDG procedure have the venous 
collateral vessel associated with several alterations of the physiological hemodynamics 
[48], [49]. [48], [49]. The aim of the study was threefold (i) how to build a patient-specific 
model and describe the hemodynamics with VVC presence (ii) quantitative hemodynamics 
prediction by performing virtual VVC (iii) compare the prediction with measurements 
obtained from post-operation. Four months after undergoing the BDG procedure, the stage 
two patient was diagnosed with VVC. To improve the O2 saturations, closure of VVC is 
performed. Closure of such collateral can have unintended consequences such as alteration 
in systemic blood flow or elevation of pulmonary artery pressure.  
The LPM layout for this study was similar to the one presented in Kung et al. [50] ... [50]. 
In addition, the VVC resistance was placed between the single atrium and the SVC, and 
the aortopulmonary collateral vessels resistances connecting the aorta to each PA branch. 
A multi-domain model of the four-month-old patient’s circulation was developed by 
following the methodologies described by Corsini et al. [51] .[51]. To account for the 




lungs, scaling factors were applied to the RLC circuit using the allometric equations [52], 
[53], [54] [52], [53], [54]. PVR and SVR lower and upper values obtained were compared 
to the patient-specific models. Differences between the three couples of vascular 
resistances suggest that growth occurred in the four months after BDG surgery, and hence 
consideration is needed in the post-operative LPM development. To obtain the eight-month 
flow and pressure, the patient-specific LPM was tuned with four-month heart parameters. 
The 3D virtual BDG, coupled with eight-month LPM, runs a pulsatile simulation and then 
matches with clinical data. Another simulation was conducted by removing the VVC 
resistance from LPM that is equivalent to the VVC closure.  
Based on the growth factor, the PVR and SVR lower and upper values should have dropped 
by 22, 25, and 13%, respectively. Results showed that this did not correspond to the patient-
specific values that indicated a 17% increase in PVR, 37% decrease in SVR lower, and 
51% decrease in SVR upper. A recent study showed that PVR increases due to abnormal 
pulmonary flow that may alter the pulmonary vascular tone [55]. [55]. The PVR 
vasoconstriction may have occurred due to non-physiological pulmonary flow due to the 
BDG surgery on this investigated patient. This study's lack of extensive data led to 
assumptions regarding parameters required to calculate the blood flow. These hypotheses 
were based on mathematical relationships and reasonable assumptions. Vasodilation in the 
upper body and vasoconstriction in the pulmonary vasculature in accordance with the SVC 
and PA hypertension lead to the VVC formation [48]. [48]. Based on the clinical findings 
of VVC formation after the BDG surgery [48], [49]. [48], [49]. VVC development on the 
post-stage-2 model could be indicated based on the predicted SVC pressure, pulmonary 




Chiara et al. [47] state that such a study could motivate data collection such as O2 
saturations, systemic blood flow, and critical clinical outcomes. This study highlights only 
one clinical case, and the developed approach can be applied to other patients if 
heterogeneous patient-specific data were collected at different intervals. The introduction 
of patient-specific modeling for growth and adaption with existing clinical data is not 
feasible. Assumptions made in the allometric equations are high and only applicable to data 
collected at two large intervals.  
The study of Zhou et al. [56] [56] focused on assisted bidirectional Glenn (ABG), an 
alternative to the mBT procedure; this was initially proposed by Esmaily-Moghadam et al. 
[57][57]; the proposed procedure remains similar to the BDG but with an accessory shunt 
that is added between the innominate artery to the SVC. Their study focuses on harvesting 
the potential energy in the blood within the systemic arteries and increasing the pulmonary 
flow using an ejector pump concept. The use of ABG has two advantages over Norwood 
as it improves the systemic and coronary perfusion by reducing the volumetric overload on 
the single ventricle [57], [58] . [57], [58]. Secondly, this reduces thrombotic risk by 
providing stable pulmonary flow. Multi-scale in-vitro models were developed to compare 
with Norwood candidate and previous multi-scale numerical simulation. Local 
hemodynamics are considered in such multi-scale simulations by providing appropriate 
boundary conditions to the anastomosis sites, this has been consistent with the clinical 
measurements [38], [50], [57], [58], [59], [60], [61], [62].Local hemodynamics are 
considered in such multi-scale simulations by providing appropriate boundary conditions 
to the anastomosis sites, this has been consistent with the clinical measurements.Local 




boundary conditions to the anastomosis sites, this has been consistent with the clinical 
measurements [38], [50], [57], [58], [59], [60], [61], [62]. 
The MFL used for their study uses the LPM network model coupled with 3D models of the 
pulmonary artery, anastomosis sites, and aorta. Several resistance and compliance values 
were scaled during each circulation based on the body surface area or by using clinical 
values [61], [62]. Vukicevic et al. [62][61], [62]. Vukicevic et al. [62] was followed in 
modeling the resistance and compliance. PVR has effects on postoperative recovery and 
hemodynamics of the infant [63], [64]. Cases that included high and low PVR were 
replicated on the testbed [57] . [57]. In-line elastic tubes and trapped air were used as 
pulmonary compliance [62], [65]. A 3.5 mm diameter shunt was used on the Norwood 
circulation, and a 2.5 mm  diameter shunt with a nozzle on the ABG circulation.  
Resistance values were set according to the steady flow conditions. Measurement of air 
volume and volume change with pressure change was used to set the compliance value. To 
achieve the mean aortic pressure, ventricular assist device (VAD) pressure was adjusted, 
and the aortic compliance element was adjusted to achieve the required aortic pulse 
pressure. The numerical simulation uses a multiscale modeling approach, coupling the 
closed-loop model to the local hemodynamics [60]. [60]. A 3D model along with a 0D 
LPM was used to represent the heart and closed-loop model.   
Using the low and high PVR values on the three circulations, the tests were conducted. 
Results showed that there was no significant difference in the mean flow rate between 
numerical and experimental analysis. Pulmonary flow rate and pulmonary pressure for the 
mBT circulation were the highest. In mBT circulation, as PVR increased, the 




decreased in both ABG and BDG circulations. SVC pressure in ABG showed 2-3.7 mmHg
higher than BDG. The pulmonary flow rate of ABG provided a 30-38% improvement 
compared to the BDG. Pulmonary pressure was lowest for BDG circulation. The ABG 
provided the highest systemic oxygen delivery compared to the other three circulations, 
irrespective of the PVR. Comparison between the numerical and experimental ABG model 
showed that RPA and LPA flows and pressures are well produced. SVC flow predicted 
numerically displayed pulsatility during systole, a possible mismatch in compliance 
between models [62]. The mean SVC pressure did not show any significant difference.  
Zhou et al. [56] stated that the initial aim of their study was to test the physical feasibility 
of the ABG circulation and validate the results against the numerical model. By comparing 
the pressure gradient between the PA and SVC relative to the pulmonary blood flow, the 
effect of the ejector shunt used can be computed. The local flow resistance is reduced at 
the PA-SVC junction by this ejector-shunt. However, with the current shunt, pulmonary 
artery pressure and SVC pressure increased about the same value. Using the ABG 
circulation procedure in place of Norwood would reduce the number of surgeries from 
three to two. The shunt used in the ABG palliation can be shorter compared to the mBT 
shunt. The flow through the shunt is drawn from the aorta providing blood at a higher 
pressure and velocity. This will eventually reduce the risk of thrombosis and cyanosis due 
to better pulmonary blood flow. The circulation is simplified to the Glenn circulation in 
the event of mBT shunt occluding. An increase in the pulmonary arterial blood flow 
increases the pulmonary arterial pressure and improved saturation over the Glenn [66], 
[67]. McElhinney et al. suggest that pulmonary arterial pressure would improve exercise 




Ethan et al. [50] study focused on the virtual Hemi-Fontan model along with a multi-scale 
simulation that predicts the patient’s hemodynamic and physiologic condition post-
operation. The patients were five and six months old, respectively. The computational 
model contained a 3D domain of the surgical junction along with a circulatory system that 
describes the 0D domain. The resting and active conditions of the two patients were 
considered, and a total of four simulations were performed.  
The circulatory system in their study was modeled using 0D lumped-parameter network 
(LPM). Five main circuit blocks were modeled to represent the heart, right and left 
pulmonary vasculatures, and the upper and lower body vasculatures. The atrium and 
ventricle were represented as elastances. Non-linear diodes are used to model the aorta 
valves along with atrioventricular valves; this allows the unidirectional flow with 
resistances proportional to the flow rate. The kidney, liver, and intestine were modeled as 
the lower body and a venous valve in the leg venous block. Based on the outlet of the 3D 
model, the pulmonary circulation is described using the  RCR blocks are arranged 
parallelly. Coronary circulation, respiratory effects, and gravity are neglected [68]. 
Pulmonary LPM parameter values were described using a morphometric tree-based 
impedance approach [69], [70] Systemic LPM parameters were represented using a  
healthy adult with  BSA= 1.8 m2 [71], [72], [73] Parameters were scaled by using the 
allometric equations according to the patient’s BSA [54] . The LPM was tuned using the 
resistance of the upper and lower body to simulate the patient’s resting condition. Patient-
specific compliance was computed after modifying the resistance of each block while 
keeping the proportion of impedance [52] [54]. The parameter values of large vessels and 




clinical measurements during the resting condition. A set of LPM parameters that is 
equivalent to active conditions was prescribed. The active state of the infant is compared 
to the exercise state of an elderly patient. In the active condition, an assumption is 
considered where the heart rate is generally around 120-160 bpm  [74]. 
The entire circulation system was developed computationally by coupling the 3D 
anatomical model and the 0D LPM model. An implicit coupling algorithm was used to 
apply the Neumann boundary condition at the inlets and outlets of the 3D model [38]. Wall 
shear stress (WSS) and particle residence time (PRT) was computed, pressure and flow 
information was extracted from various points along with the instantaneous pulmonary 
power loss.  
Results showed that the flow from SVC transitioned smoothly into the pulmonary arteries 
for patient A and swirling was observed for patient B, resulting in high velocities near the 
circumference. WSS distribution plot in the surgical junction for both patients is uniformly 
distributed; the band of high WSS characterizes the orientation of swirling flow. The power 
loss results obtained are similar to previous modeling studies of the HF anatomy [75], [76]. 
Patient B showed three times higher power loss due to higher flow rates and flow 
disturbances. There was an increased CO during the active condition, and in the pulmonary 
blood flow, this increased the SVC pressure in both models. Coupled with the existing 
SVC baseline pressure of 15.5, patient B had an SVC pressure of 18.8mmHg compared to 
the SVC pressure, 11.7 mmHg . Patient B would exhibit superior venous hypertension or 
SVC syndrome with headache, face swelling, and orbital edema based on prior clinical 




operational condition is smaller than the loop during the resting condition; this indicates 
that during each cardiac cycle, less work is performed.  
Ethan et al. concluded the study by mentioning that further refinement is required within 
the HF operation. Improving the surgical junction power loss has minimal impact on the 
overall post-operative circulation in pressure and flow during the resting and active 
conditions. PRT and WSS results from computation can assess the relative thrombotic risk; 
this can be reduced if the PRT values are lower. Platelet activation is possible when the 
values of WSS are in the range of shear-induced platelet [77]. Considering the junction as 
a non-linear resistance proportional to the square of the flow rate would be the plausible 
reason for the increased surgical junction power loss during active conditions [78]. The 
difference in power loss between the two Hemi-Fontan models could affect systemic 
parameters during strenuous activity [79]. 
Schiavazzi et al. [80] study focused on the postoperative hemodynamics of LPA stenosis 
by using a multiscale computation study on single ventricle patients undergoing stage II 
superior cavopulmonary connection (SCPC). Postoperative stenting or surgical 
arterioplasty is often required to relieve LPA hypoplasia or stenosis [81], [82], [83], [84], 
[85]. This adds complexity and time to the SCPC operation. The treatment of LPA stenosis 
is still subjective and needs to rely on angiography data and clinical experience. This study 
aimed to develop quantitative guidelines for the treatment of LPA. 
Ninety patients were studied for various configurations in stenosis, in the main pulmonary 
arteries, or their branches [86]. Data showed that discrete pulmonary artery stenosis was 
frequent when combined with other anomalies. The local compression induced due to 




[82], [83] [87]. This affects the ventricular-arterial coupling [88] that results in increased 
and eccentric wall shear stresses [89].  
Magnetic resonance imaging (MRI) data of each patient before stage II surgery was used 
to develop the 3D models of the junction between BT shunt and pulmonary arteries. 
Relevant vasculature was obtained using the combined segmentation and region-growing 
technique [90]. The LPM model was constructed using a circuit model [72] to simulate the 
preoperative and postoperative patient’s circulatory physiology[50],[51],[52], [91]. The 
heart, upper and lower systemic, and left and right pulmonary circulations are characterized 
using five circuit blocks; the remaining modeling technique is followed by the model done 
by Migliavacca et al. [68] The LPM model was coupled with the 3-D streamline upwind 
Petrov-Galerkin finite element navier-stokes solver [60], [92].  
Results showed that LPA: RPA in patient P1 was weakly affected due to the severity of the 
stenosis. The ratio in patient P1 was higher than the average compared to the flow split 
ratio when at 80% stenosis and 35% stenosis. Between Glenn and Hemi-Fontan models, 
all levels of stenosis showed a maximum relative difference of 4% in patients P1 and P3. 
For a degree of stenosis at 60% of the diameter, the maximum relative difference in 
pressure drop across the LPA was higher. A mean pressure drop of greater than 3mmHg 
across the stenosis is considered clinically significant [84]. 
There was no change noticed on the pressure-volume loop for severe levels of stenosis. No 




, power losses, systemic 
and venous oxygen saturation. Pressure and LPA: RPA flow split falls in the range of 




required in more than 50% of the cases, as pulmonary artery distortion and hypoplasia 
occur most often in LPA[83], [84]. During stage II surgery, augmentation of central 
pulmonary arteries is essential, while minimizing pulmonary artery distortion is the 
primary factor to use the Hemi-Fontan rather than bi-directional Glenn. Treatment of 
pulmonary stenosis is performed to avoid potential effects on suboptimal growth and 
exercise tolerance and remodeling caused by reduced flow [93], [94]. Simulations were 
performed, keeping all other modeling parameters constant. Results show that power loss 
in the SVC-pulmonary artery junction is a small fraction of the total pulmonary power loss. 
Parameters of clinical interest remained unchanged.  
Schiavazzi et al. [80] concluded the study stating the limitations faced in the study as LPM 
parameters were identified based on preoperative stage II clinical data. This approach is 
under the assumption that there are minor physiological changes in the patients. Pulmonary 
and cardiac dysfunction in the early postoperative period was not considered. The clinical 
data used for this study came from a patient under sedation. Change in the flow into the 
pulmonary arteries can influence the result. 
Moghadam et al. [57] study focused on a novel surgical approach by using an ejector pump 
for the flow in BDG to be assisted. The highest mortality was observed [95] in an initial 
report of the classic Glenn procedure in patients. Inadequate pulmonary blood flow and 
SVC syndrome were the primary reasons for death. Less formal attempts to use this 
procedure have led to similar poor outcomes [96] [97] [98]. 
An ejector pump can be used in the SVC circulation, where the low-energy blood flow in 
SVC can be assisted by additional energy from flow in the systemic circulation. By 




in PVR due to infant physiology. To couple local hemodynamics to a closed-loop model, 
a multiscale framework is adopted [99]. An LPM network along with a 3D model of large 
vessels for which Navier-Stokes equations have been solved. The 3D geometric model was 
constructed based on the former study of the mBT shunt [38]. Three models were created 
using realistic anatomy and clinically derived geometries. A 3.5 mm mBT shunt, the SVC 
diameter was 4.5 mm , a 2.5 mm  shunt was used in between the innominate artery and the 
SVC for the ABG approach. The adopted LPM is based on the prior studies of the mBT 
shunt circulation [100]. Component values for the blocks were obtained from the 
angiographic data of 28 Norwood patients. A total of six simulations were performed to 
examine the influence of high PVR during the early postnatal period. 
Results showed that for ABG procedure without the distal clipping, at lower PVR, SVC 
pressure increased, pulmonary flow increased, and oxygen delivery decreased. Once the 
clipping is done, the upstream pressure from the SVC shunt is lower than the downstream 
pressure. The energy in the flow is partly transferred to SVC from systemic, thereby 
making the ejector pump concept feasible. The BDG model lowers the cardiac output, 
maintains the oxygen delivery, and has higher SVC pressure compared to the mBT shunt. 
Compared to BDG, the ABG had improved pulmonary blood flow, and the ABG model 
achieved the highest oxygen delivery and oxygen saturation with the presence of PVR.   
Moghadam et al. concluded the study stating that early application of BDG as first stage 
palliation has been avoided based on outcomes. The ABG provides a different strategy; 
based on the results obtained, complications from Glenn can be avoided. High SVC 
pressure at high simulated PVR based on neonatal period remains a concern for ABG 




early thrombosis due to lower flow residence as the length of the shunt is shorter than the 
mBT shunt. Mathematical models cannot predict all biological responses, hence the need 
for an animal model to examine the ABG shunt thrombosis. 
Arbia et al. [101] study focused on the use of CFD in cardiovascular research to model 
hemodynamics changes due to pathology [70], [102] [103] [104], changes due to surgical 
repair [51], [105]  and explore possible different scenarios for treatment [38],[50],[61], 
[106], plan therapy [107]  , design artificial devices or conduits that are subjected to stress 
and pressure due to the blood flow [108] [109] [110]. 
To achieve an effective solution, necessary steps are taken to simulate blood flow that 
includes geometrical mesh generation from image data, the required boundary conditions, 
and the choice of numerical algorithm to compute flow and pressure. Inaccurate 
performance in the numerical algorithm can lead to an erroneous result and thereby leading 
to a misleading conclusion. Governing equations are discretized in space and time to 
compute the solution close to the exact solution. Finite volume and finite element are two 
discretization methods in space, within whom many variants existed for Navier-Stokes’s 
equations [111] [112]. 
Arbia et al. discuss the use of computational fluid dynamics on superior cavopulmonary 
connection (SCPC). The exact solution for the flow equations cannot be derived 
analytically due to its complex geometry, compulsory three-dimensionality, and flow 
characteristics. The SVC anastomosis was reconstructed from MRI data of SVC following 
the Glenn operation. The geometric complexity with the most straightforward 
hemodynamic setting is used to see its influence on the solution. Steady flow condition 




the wall. Using rigid-walled models will yield identical results regardless of the values used 
for reference. A uniform mesh was generated, and a mesh comparison study was 
performed. Results showed that mesh had a very minimal impact on the SVC pressure and 
the flow split between two lungs. The change in the SVC pressure was clinically negligible 
as they correspond to a small fraction when converted to mmHg. 
The above literature discusses the conventional comprehensive stage II procedure with 
patient-specific data applied on in-vitro and in-silico models and compares the data with 
clinical generated data.  
DeCampli et al. [113] study focused on a hybrid approach to the comprehensive stage II. 
The “hybrid Norwood” consists of a procedure that is performed without the need for 
cardiopulmonary bypass. This has a putative advantage in the avoidance of surgical trauma. 
After using this approach, the outcome from various centers has been laudable, while others 
report intermediate-term outcome that is not better when compared to the stage I palliation 
[114], [115], [116] [117]. Deep hypothermia, circulatory arrest, and cardiopulmonary 
bypass are required for comprehensive stage II palliation. Due to band-induced trauma, 
bilateral pulmonary artery reconstruction is required and the management of the ductal 
stent. To reduce the real trauma of the patient, an alternative technique for comprehensive 
stage II palliation is proposed as shown in Figure 12. This applies to patients who can 
sustain the upper body perfusion by having sufficient antegrade aortic flow. The creation 






Figure 12 Hybrid Comprehensive Stage II procedure conducted by DeCampli et al. [113] 
Two patients were considered for this study. After undergoing hybrid stage I on day four, 
Patient A had a hypoplastic aortic arch and aortic isthmus along with a sizeable ductal arch 
with no obstruction to the left ventricle. The palliation procedure begins with the heart, 
innominate, superior caval veins and great vessels being mobilized and the azygous vein 
divided. The descending aorta, distal arch, or aortic isthmus are not mobilized. Dual arterial 
cannulas were placed in the PA trunk and innominate artery. The venous cannulas were 
placed in the innominate vein and right atrium, followed by the cardiopulmonary bypass. 
Upon cooling to 18  C degrees , PTFE bands were removed from the branch pulmonary 
arteries after arresting the heart and clamping the ascending aorta. The arch branches were 
occluded, followed by PA cannula removal and the procedure for antegrade regional 
cerebral perfusion. The RPA was opened at the proposed site of the SVC anastomosis. A 
guide wire was advanced till the left lower lobe artery from the RPA incision. A baffle was 
sutured partially using a pulmonary homograft material. This was done within the 
pulmonary bifurcation from the right to the LPA orifices.  A stenting procedure was 
followed to prevent the baffle from being crushed due to the systemic flow; due to the 
surrounding systemic circulation, a considerable amount of stress is exerted on the stunt, 




Upon completion of the surgery procedure, the patient made an unremarkable recovery and 
became hypoxemic after postoperative day 5. Extensive thrombus condition was noticed 
in the intra-pulmonary covered stent, LPA, and its lobar branches. The patient succumbed 
to hypoxia on postoperative day 26.   
After undergoing hybrid stage I on day six, Patient B had a double outlet right ventricle 
and mitral atresia. A left posterior aortic root unobstructed pulmonary outlet and crowding 
in the subaortic region were seen during the echocardiography. A similar technique was 
followed, as mentioned above, for patient A. The central PA was opened longitudinally, 
and the ductal stent was trimmed back to flush along with the PA bifurcation. A homograft 
baffle was partially sutured between the left and right PA orifices. The same procedure 
performed on patient A was performed on patient B.  
Upon completing the surgery, the patient had a parainfluenza infection due to pulmonary 
compromise for a prolonged duration. The patient recovered and was discharged on 
postoperative day 53. The formation of the aneurysm on the intrapulmonary baffle was not 
revealed during the angiography study. An echocardiography study at the age saw a good 
RV function, unobstructed flow from the right ventricle, unobstructed flow from the native 
aortic root, and unobstructed cavopulmonary connection of 15 months. 
 DeCampli et al. [113] concluded the study stating that this procedure has potential 
advantages as it limits the baffle construction and arterial incision, shortened duration of 
regional cerebral perfusion, and hypothermia. The complete avoidance of mobilization and 
reconstruction of the isthmus, arch, and descending aorta decreases the risk of bleeding, 




including baffle leak, LPA stenosis, stent migration with LPA occlusion, and recurrent 
ductal arch stenosis.  
The proposed procedure requires 1-2 stents placed; stent management is common with 
conventional and standard hybrid staged approaches. Dave et al. [118] reported the 
incidence of branch PA stenting was 17% and 38% for conventional management and 
hybrid stages I and II. Reinhardt et al. [119] reported that catheter reintervention was 
required for 37% in the conventional stage approach. Studies have claimed that PA and 
aortic stents placed during the infant stage can be dilated to a diameter of an adult stent 
with an average of three interventions [120], [121], [122]. 
The HCSII procedure is proposed as an alternative technique to the comprehensive stage 
II procedure to reduce surgical trauma in patients. The HCSII procedure applies to patients 
with sufficient antegrade aortic flow to sustain the upper body perfusion. The significant 
advantage of the HCSII procedure avoids the creation of Damus-Kaye Stansel (DKS) 
connection and aortic arch reconstruction. As discussed in section 1.6, the goal of this 





2.1.3. Stage 3: Fontan  
 
Figure 13 Stage 3 Fontan 
Francis et al. [123] performed the third stage operation on patients with tricuspid atresia to 
route blood from vena cava into the pulmonary circulation, as shown in Figure 13. The 
right atrium is bypassed and returns the oxygenated blood to the left side of the heart. As a 
result, the systemic and pulmonary circulations are connected in series. The advantages of 
the Fontan procedure are decreased load on the ventricle and better oxygen saturation. In 
addition, flow through the pulmonary circulation is driven by the mechanical energy from 
the post-capillary action. The downside of the Fontan procedure involves chronic 
hypertension in the systemic vein [124]. Higher caval pressure is seen in the Fontan patients 
due to the lack of a pump downstream of the systemic veins. As a result, the cardiac output 
decreases as the ventricle pumps against the pulmonary and systemic resistance connected 




Choussat and Fontan stated that the patient must have good cardiac output and systemic 
pressure at an acceptable value for the operation to be conducted [124]. In addition, the 
patient must have good pulmonary arteries such that resistance in the pulmonary circuit is 
not high. An ideal patient for the Fontan procedure will have a good ventricular function 
and unobstructed ventricular flow. Fontan operation cannot be performed when the patient 
is born as the veins are small and their corresponding resistance is high [124]. Hence, a 
three-stage procedure is followed to allow the body to adjust to different hemodynamics 
conditions introduced by the third stage.  
When the patient attains 1-5 years old, based on the cyanosis at rest and during exercise 
and the growth of the vascular structures, the stage III procedure is performed on the 
patient. In the stage III procedure, the IVC is connected to the pulmonary artery. The two 
methods for connecting to the pulmonary artery are Atriopulmonary connection (APC) and 
TCPC. The right atrium acts as a valveless contractile chamber between the great systemic 
vein and the pulmonary artery [125]. The problem associated with the APC connection 
involves no ventricle to supply power, and the APC connection operates at a higher 
pressure. In vitro studies have shown a loss of mechanical energy due to turbulence 
generation when a compliant atrial chamber is placed in between the pulmonary arteries 
and systemic veins. Superiorventricular arrhythmias and chronic atrial distension are 
caused due to the APC technique making it an inefficient method within the Fontan 
procedure [126]. 
In the TCPC procedure, IVC and SVC are directly connected to the pulmonary artery, 
making the TCPC procedure superior to the APC procedure. IVC can be connected to the 




1980s. A channel exists between the IVC and the pulmonary artery via a portion of the 
lateral atrial wall and a prosthetic baffle in this technique. This method is used on younger 
patients as the connection grows along with the patient [124]. The lateral tunnel method 
leads to arrhythmias over a period of time as a small portion of the atrial tissue is exposed 
to higher pressure. The second method is the extracardiac conduit method developed in 
1990 [127] . In this method, a graft tubular in shape is placed in between IVC and 
pulmonary artery. The right atrium is at low pressure, and the right side of the heart is 
bypassed. The extracardiac conduit technique is available to patients who have grown large 
enough such that the graft can be placed for the IVC flow and must have high Pulmonary 
Vascular Compliance [124], [127]. Pleural effusion and protein-losing enteropathy are 
associated with this technique if conditions are not met [128]. 
2.1.3.1. Extra cardiac and intra cardiac Fontan 
Alexi- Meskishvili et al. [129] conducted a clinical study to obtain the optimal size for the 
Gore-Tex conduit for extra cardiac Fontan operation (ECFO). Recommendations to choose 
the conduit diameter were based on minimizing the risk of thrombosis, and the diameter 
should not exceed the diameter of IVC by 20%. It was recommended to perform ECFO on 
patients between 2-4 years old as the distance from IVC to RPA is about 60-80% of an 
adult. 
Itatani et al. [130] conducted a study using CFD analysis to determine the conduit size of 
the ECFO procedure. Optimum conduit size must be determined to balance the risk 
associated with energy loss, flow stagnation, and thrombosis. When a smaller conduit is 
used, there is a lesser chance for flow stagnation, as flow moves faster. In addition, higher 




must be large enough to avoid energy loss and flow stagnation as flow stagnation leads to 
blood clotting, leading to catastrophic consequences for the patient. The variations in flow 
are driven by respiration, making it non-pulsatile in nature. For different conduit sizes, 
stagnation volume and energy loss were measured at rest and exercise; it was identified 
that stagnation occurs during expiration. Stagnation decreased during exercise as the 
overall flow rate increased. For patients as old as 2-3 years, conduit size lies in between 
16-18 mm in diameter.  
Penny et al. [131] studied the role of the lungs after the Fontan operation, where the sub-
pulmonary atrium was connected to the pulmonary circulation. The study examined the 
right atrium's role in supplying energy related to pulmonary blood flow’s energy provided 
by respiration. At expiration, the contribution of the right atrial to the forward flow was 
51.4%, with a standard deviation of 8.8%. During inspiration, the total forward flow was 
63% higher than expiration, with a standard deviation of 35%. The contribution of the right 
atrial to the forward flow was 52% during inspiration, with a standard deviation of 10%. 
Hsia et al. [132] conducted a study on the effect of respiration and gravity on the flow in 
the systemic veins in patients with Fontan and normal biventricular circulation. The Fontan 
patients studied underwent TCPC and APC operations. The TCPC operation was further 
divided into lateral tunnel method and extracardiac conduit. Patients who underwent TCPC 
had significant fluctuations in the flow in the primary vein that returned from the liver and 
the hepatic vein. Respiration effect was seen lower in APC operation compared to TCPC 
operation. The average ratio of inspiratory to expiratory flow was 1.6 for APC patients, 3.4 
for TCPC patients, and 1.7 for the control group. The inspiratory to expiratory flow ratio 




The gravity effect did not significantly affect the net forward or retrograded flow for 
patients with normal circulation. For APC and TCPC patients, gravity reduced the net 
forward flow and increased the retrograde flow. 
Redington et al. [133] conducted a study on pulmonary artery respiration in patients with 
a total cavopulmonary shunt. Patients have their right heart bypassed, and venous blood 
from the liver and coronary sinus enters the right atrium. During inspiration and expiration, 
blood flow increased and decreased in the pulmonary artery. Flow measurements were 
made using Doppler echocardiography in the pulmonary artery.  
Hjortdal et al. [134] conducted a study on the relationship between respiration and blood 
flow during exercise and rested in Fontan patients with TCPC. Flows in the IVC and SVC 
were monitored using MRI. SVC flow was not affected by respiration when the patient was 
at rest. The inspiratory to expiratory flow ratio was 1.0 along with a standard deviation of 
0.2; exercise did not significantly affect the ratios. During respiration, the IVC flow was 
higher. The mean ratio of the patient at rest was 1.9, along with a standard deviation of 0.5.  
Twice, the amount of flow in IVC during inspiration and exercise was driven by ventricular 
activity, decreasing the ratio. 
Mardsen et al. [135] conducted a study to understand the effects of respiration and exercise 
on the TCPC using CFD analysis. In this study, realistic hemodynamic data was produced 
that is close to clinically measured data. The exercise hemodynamics was affected due to 
the respiration model. 
Hsia et al. [136] conducted a study on the effect of diaphragm plication, a surgical 
procedure done on normal and Fontan patients to relieve symptoms of diaphragm paralysis. 




IVC. Fontan patients under this study had TCPC operations. The normal control group had 
a hepatic venous flow of 2.4 times higher during inspiration than expiration in the upright 
position. Patients with diaphragm plication had a ratio of 1.4, showing the effect of 
respiration diminished. In Fontan patients, the hepatic vein flow ratio was 3.2 in supine for 
normal diaphragm position; for diaphragm plication condition, the ratio was 2.3. The 
effects of respiration on systemic venous flow are essential in Fontan patients; for a patient 
with diaphragm plication, this effect is lost. The phrenic nerve injury should be avoided by 
all patients who have or will receive the Fontan operation.  
Hsia et al. [137], de Level et al. [138], Mardsen et al. [135], and Bove et al. [139] performed 
studies to modify the surgical procedure that could improve the Fontan hemodynamics. To 
understand the effect of different design parameters on hemodynamics effect, CFD analysis 
was performed. Parameters included effects on alternative Hemi-Fontan procedure, 
inferior cavopulmonary connection (ICPC) diameter, Y-shaped ICPC, and ICPC location.  
Ovroutski et al. [140] conducted a study on the effect of the Fontan operation on oxygen 
and exercise capacity. Patients who had TCPC procedures, both adults and children, were 
studied. Patients were monitored early and late postoperative exercise phase. During the 
early phase, the mean cardiopulmonary oxygen capacity was higher in children than adults, 
27.9 /ml min
kg
 and 22.9 /ml min
kg





 in children and adults. Cardiopulmonary oxygen capacity in adults and 
adolescents decreased compared to early and late postoperative. The exercise capacity was 
better in children compared to adults. The median value for children was 2.2 /W kg and 




observed during early and late postoperative. The median rate was 136 bpm and 112 bpm 
for children and adults.   
2.1.3.2. Fenestration and PVR 
Gewillig et al. [124], [141] [142] [143] mention the need to address the pulmonary 
vasculature in sick Fontan patients. Fenestration is a procedure that bypasses pulmonary 
vasculature by returning IVC blood flow to the right atrium; this reduces IVC flow 
congestion and improves cardiac output. Due to this process, the oxygen saturation 
decreases, and identifying the optimum fenestration size has been difficult. A high level of 
cyanosis can occur due to excess return flow, and smaller fenestration may not efficiently 
reduce the IVC congestion. Ventricular dysfunction is the other main failure component. 
Henain et al. [144] conducted a study on the effect of pulsatility on PVR by implanting 
cavopulmonary shunt in 30 pigs surgically. Measurement on three control groups revealed 
that PVR and pulmonary arterial pressure increased due to lack of pulsatility. 
Goldstein et al. [145] analyzed the relationship between exercise capacity to diastolic 
function and PVR. PVR decreased with exercise but remained constant in some patients. 
It was found that in Fontan patients, the limitation on exercise was controlled by PVR. 
Shachar et al. [146] found that PVR decreases during exercise in four of the five Fontan 
patients studied. The relationship between the PVR and exercise is still not known. 
Reeves et al. [147]   conducted a study on the normal human lung distensibility during 
exercise rather than total PVR. A two percent increase in vessel diameter was seen for very 
one mmHg pressure in the isolated arterials. The flow pressure increases during exercise 
cause dilation in the lung vascular bed by 40%. An increased pulmonary flow was seen 




Forton et al. [148]measured the pulmonary arterial pressure (PAP), pulmonary flow, 
exercise capacity, and PVR of healthy adult volunteers using Doppler echocardiography 
under different exercise conditions. At peak exercise in all exercise conditions, the PVR 
reduced by 40%. 
Naeije and Chesler [149] stated that PVR is flow-dependent and it decreases curvilinearly 
as the flow increases. The cardio output decreases as aging increases PVR. Vasodilators 
such as nitric oxide and prostacyclin are released by pulmonary endothelium during 
exercise, reducing the PVR. To detect dilation or constriction of pulmonary vessels or 
changes in the arteriolar vessel caliber,  PVR can be used as a good indicator. 
Schmitt et al.  [150] studied ten Fontan patients' effects on collateral blood flow and PVR 
before and after administering dobutamine stress. Measurements were taken using MRI 




during free breathing. Cardiac output increased due to decreased systemic vascular 
resistance, and no effect was seen on PVR when administered dobutamine. Due to the 
increased cardiac output, the PVR decreased.  
Rivera et al. [151]studied the relationship between PVR and pulmonary venous blood flow 
during oxygen inhalation and free breathing. The study was done on 18 patients with CHD 





was measured. Measurements were taken before and after 100% oxygen inhalation (10 





Petrofski et al. [152] conducted a study on lowering PVR using mechanical ventricular 
support. An adult patient with elevated PVR and heart failure was taken for this study. The 
PVR decreased from 13.8 to 3.1 Wu after 24 hours of mechanical support to the pulmonary 
and systemic systems. 
2.1.3.3. Morbidity and Mortality 
The life expectancy of patients undergoing the Fontan procedure will usually be two or 
three decades of a semi-normal life. The side effects caused due to this procedure lead to 
congestive heart failure. Level et al. [125] states that reduced cardiac output and elevated 
systemic venous are the primary reasons for complications. The elevated systemic venous 
pressure causes plastic bronchitis, liver failure, and protein-losing enteropathy. Increased 
lymph production is associated with elevated systemic venous pressure, which leads to 
impairment in lymphatic resorption that leads to protein-losing enteropathy. As a result, 
the patient experiences reduced exercise tolerance. The lack of ventricle causes flow 
pulsatility in the pulmonary circulation, and hence the pulmonary compliances gradually 
reduce over time.  Stiffness is increased in the pulmonary circuit due to dilation that arises 
from a lack of pulsatility. Higher pulmonary vascular resistance is seen due to increased 
stiffness, which means lower cardiac output due to high systemic venous pressure. Hsia et 
al. [132] state that gravity reduces the forward venous flow in patients. 
Cavalcanti and Silvio [153] studied the failing Fontan operation to determine its factors 
and correlation with the failing Fontan circulation. The hypothesis stated that the Fontan 
operation's success or failure depends on the anastomosis site. Patients were categorized 
into two groups for this study: symptomatic Fontan failure and no symptomatic Fontan 




arterial pressures between the two groups. The failing Fontan group had higher pressure at 
the end of the pulmonary vein. Pressure in the SVC and IVC was 5.4 mmHg and 6.8 
mmHg  higher. The mean cardiac output of the failing Fontan group was 36% lower, 
pressure loss over the cavopulmonary connections was higher; this was more significant in 
the IVC connection. The total energy loss was studied across the cavopulmonary 
connections between the two groups. The failing Fontan group had higher energy loss in 
the inferior SVC. No statistical significance was seen in the energy loss in the superior 
SVC. The possibility of reducing these elevated pressure drops depends on minimizing the 
resistance and energy loss within the TCPC. 
2.1.3.4. In-vitro and in-silico approach 
Snyder et al. [73] developed a numerical model of the cardiovascular system for NASA. 
This model included the LPM approach to model characteristics of every branch of the 
circulatory system. The LPM took into account the effect due to resistance, inductance, 
and compliance. For this study, a three resistance-compliance element was used to model 
the pulmonary system based on the average flow and pressure values. This model is split 
into four sections, the head, thoracic cavity, abdominal cavity, and lungs. Additional 
pressure generators and grounding relevant compliances to intrathoracic or abdominal 
pressure were done, including gravity and respiration in this system. In modeling the 
Fontan circulation, patient data is necessary as the patients have different pulmonary 





2.1.4. Passive and Active techniques to improve Fontan 
To power the pulmonary system, mechanical assist devices have been proposed [154] [155] 
[156] [157] [158] [159]. These mechanical devices have successfully dropped the IVC 
pressure back to the normal value of 8 mmHg theoretically. Some current issues include 
the requirement of two pumps, re-circulation induced by barriers, pumping in one direction, 
obstruction, and the device cannot be shut off. With fenestration, these issues can lead to 
pulmonary embolisms, driveline infection, or stroke [154]. 
Self-powered Fontan is the technique to tap the reserve mechanical energy of the native 
heart and inject it into the Fontan system. The IJS is placed from the aorta to the Fontan 
conduit. Assessment of energy losses due to flow mixing and flow jet impingement is 
critical. Understanding the alternative surgical technique requires a multi-scale 3D and 0D 
CFD analysis. The full 3D CFD model is tightly coupled to the LPM model, and the 0D 
model does not model the TCPC. The pulmonary flow is tuned to increase by 50% in this 
IJS model, directly affecting the PVR. Accurate PVR vs. flow models are not available as 
other studies include other responses such as exercise, dobutamine stress, and oxygen 
inhalation [145],[146],[147],[148],[149],[150],[151],[159], [160].  
To have a maximum pressure drop at IVC, the IJS configuration was optimized. The nozzle 
diameter and location were optimized using steady-state study conditions in a CFD model; 
it was later implemented into three different models. Children’s Hospital of Philadelphia 
gave a patient-specific model through MRI scans [75], [161], and synthetic models were 




2.1.4.1. Ejectors and Nozzles 
Brahim et al. [162], Kandakure et al. [163], Yadav et al. [164] conducted a study on the 
effect of liquid to gas mixing using ejectors in a convergent-divergent mixing chamber. 
Design parameters such as nozzle to throat area ratio, primary to secondary flow ratio, 
throat to nozzle length, and nozzle diameter were analyzed to optimize mixing, mixing 
efficiency, and entrainment. Low entrainment rates are observed as the driving pressure 
decreases due to a decrease in pressure. 
Mukherjee et al. [165] conducted a study to analyze liquid to liquid dispersion efficiency 
using ejectors. Energy loss could be minimized by selecting the optimal primary to 
secondary flow ratios and the correct throat to nozzle area ratio. A decrease in efficiency 
is attributed to mixing, flow channel shape, and friction. 
The stage III literature mainly focuses on various alternative techniques to improve the 
efficacy of the procedure. Along with the alternative techniques, the study on PVR, a 
critical hemodynamic parameter, is conducted. Researchers have studied various factors 
that affect the PVR, and the goal is to reduce the PVR in Fontan patients as complications 
arise after the surgical procedure. The usage of injection jet, a passive technique to improve 
the Stage III procedure, is proposed and discussed in section 2.1.4. As discussed in section 
1.7, the goal of this research is to validate the in-silico simulations by performing the in-
vitro simulation. 
 
2.2. Mock Flow Loop 
The MFL is a mechanical representation of the human cardiovascular system for in vitro 




other cardiovascular devices. The MFL consists of resistance valves that provide constant 
flow by altering the pressure. Newer MFL includes additional features such as 
compliance resistance, fluid inertia, pulsatile flow, atrial contraction, pulmonary and 
systemic circuits.  
The first MFL was developed to test the artificial heart valve; the artificial heartbeat was 
created using pulse duplicators driven by stepper motors [166]. For valve flow 
visualization, many systems included transparent and flexible ventricles [166], [167] [168] 
[169] [170] [171] [172] [173]  
Cornhill et al. [173] developed an MFL to test prosthetic heart valves. The MFL had a 
collapsible silicone bag in a pressurized airtight box to mimic the left ventricle. The left 
ventricle was supplied with pulses of compressed air, controlled by a solenoid valve. The 
system having characteristic impedance, total arterial capacitance, and peripheral 
resistance reproduced conditions to test the artificial heart valves. The system failed to 
simulate the atrial systole, and inertial effects were ignored.  
Kolff et al. [174] developed an MFL that consisted of both systemic and pulmonary sides. 
The ventricles were operated using compressed air. Tall columns of water obtained 
pressures in the pulmonary artery and aorta. Diastolic pressure could be changed by 
changing the height of the fluid column. The excessive inertia produced by the water 
columns had to be overcome to move the fluid up the tube. The inertia was overcome by 
using a pressurized air chamber that surrounded the bottom half of the tube. For this MFL, 
resistance valves were not used as resistance increased with increase inflow. 
 Reul et al. [175] developed an MFL using the flexible tube for the aorta and its branches. 




Windkessel chamber with adjustable air volume for compliance. A tube membrane was 
used to apply resistance to each branch of the system. The MFL was driven by a cam system 
that supplied the pulsatile pressure to the mock ventricle. Inertance in this MFL is taken 
into account by dimensioning the aorta and its branches. The MFL mimicked the systemic 
circulatory system but did not include a method to connect and test VADs. 
Donovan et al. [166] developed an MFL to test new artificial hearts in in-vitro conditions; 
the cardiovascular device testing capabilities of the rig are limited due to the absence of 
atria or ventricles. This system was compact and showed positive results in comparison to 
the calf model. 
Scotten et al. [176] developed an MFL to evaluate mitral valve prostheses. A cam created 
a transparent mock ventricle and was driven to push the fluid in a sealed chamber that 
includes the ventricle. The ventricle volume was found concerning time by examining the 
cam position and the cam’s cross-sectional area concerning time. The ventricle pumped the 
fluid into a compliant latex rubber aorta, then to the resistance and the compliance 
elements. Resistance was simulated by using cellulose fiber water filters. These water 
filters had a pore size of 5 and 50 m  for characteristics and peripheral resistance, 
respectively. The resistance values in this MFL could be altered by the cellulose fiber water 
filters into a plastic tube when the MFL was in operation; the procedure produced discretely 
variable resistance rather than a continuously variable system. Compliance for this MFL 
was obtained by the volume of air trapped above the resistance elements. This MFL 
produced pressure and flow results. 
Rosenborg et al. [177] summarized the design and evaluation of the Penn State MFL. The 




compliance, resistance, inertance, systemic and pulmonary circulation, VAD connections, 
and adjustable cardiac conditions. The values selected for the MFL with a cardiac output 
of 5 /L min , MPAP of 15 mmHg , MAP of 100 mmHg  , mean RAP of 2.2 mmHg , and 
mean LAP of 7.5 mmHg . The resistance and compliance values used for this MFL were 
based on a healthy male, as mentioned in Table 1. Inertance values were assumed to be 
equal for systemic and pulmonary circulation, which were incorrectly assumed. This MFL 
showed satisfactory results representing the human circulatory system and providing a 
suitable method for in-vitro blood pumps. 


























Verdonck et al. [178] created an MFL to test mitral valves, later altered. The MFL could 
replace the aortic and mitral valves. Fluid enters the MFL from a  preloaded reservoir 
representing the lungs into the two pulmonary veins, which carry the fluid through the 
mitral valve. The fluid from the left ventricle travels through the aortic valve into the 
afterload system that consists of a Windkessel chamber for compliance and a hydraulic 
resistor. A venous reservoir was included to obtain a constant venous pressure of 5 mmHg
. The latex atrium and silicone left ventricle were anatomically shaped and mounted in 




Perspex housing. A feedback system determined the pressure delivered to the ventricle. 
For systole, positive pressures were induced, and for diastole, negative pressures were 
used. The positive and negative pressure resulted in physiologically inaccurate ventricle 
filling. This MFL was used by Vandenberge et al. [179] to assess intra-arterial LVADs 
hydrodynamic performance.  
Trittenwein et al [180] designed a neonatal MFL to investigate the effect of extracorporeal 
membrane oxygenation. The loop was required to produce lower cardiac output with 
decreased heart rate such that neonatal conditions could be mimicked. The authors 
concluded by stating that this MFL is valuable in demonstrating conditions in neonates. 
Due to lack of patient reaction and medication effect, this cannot replace clinical studies. 
In neonates, biventricular heart failure could not be created as the system lacked pulmonary 
circulation, resulting in inaccurate simulated ventricle preload.  
Sharp et al. [181] conducted a study on the benefits of several Windkessel models from 
basic two-element to advanced five-element Windkessels. An MFL was developed and 
compared with existing MFL and natural heart results. A computer simulation was 
conducted on RC, RLRC, RCLRC, and RC models; R stands for resistance, L for inertance, 
and C for compliance. Results showed that as each element was added to the design, there 
was an improvement in results compared to the human data. Four element windkessel 
model showed slight improvement when compared to the three-element windkessel model. 
The addition of a fifth element improved the circuit significantly. Due to the difficulty in 
the construction of the RCLRC model, the RCR model was favored. 
Baloa et al. [182] studied the elastance-based control of MFL. A new control strategy for 




ventricular pressure vs. the ventricular volume of the ventricle. The maximum value of 
elastance was taken at the point of end-systole or a measure of ventricular contractility. 
The authors stated that the design was successful in using elastance-based control to the 
ventricular chamber’s contractility. The inertial effects in the circulation and ventricle were 
ignored, and only the systemic circulation was simulated.  
Fiore et al. [183] designed an MFL to study the mitral valve surgical correction. The study 
involved developing a flexible mock ventricle and studying the change of shape during the 
cardiac cycle. This information was used to study the fluid dynamics of ventricular filling. 
For this MFL, the end-systolic shape of the ventricle was chosen to keep the shape similar 
when the ventricle fills with the fluid. The ventricle was constructed using the finite 
element model (FEM) model, the structure was reinforced with five bands, and the model's 
thickness was 0.21 mm . Negative pressure was applied around the mock ventricle to 
induce ventricular filing. The system's inaccuracy did not exceed 3.5%, and the design 
behaved naturally like a left ventricle. The mock ventricle represented that of a healthy 
male. Larger ventricles volumes seen in conditions such as dilated cardiomyopathy could 
not be replicated in this MFL.  
Goodwin et al. [184] developed an infant MFL for education simulation. This study 
replicated the cardiovascular parameters of the infant.   
Pantalos et al. [185] aimed to create an MFL to mimic the Frank-Starling response in 
normal, failed, and partial recovery situations of the heart. The MFL used a flexible 
polyurethane atrium and ventricle. The ventricle was placed inside a pressurization 
chamber with a semi-rigid dome for mounting inflow and outflow valve. The ventricle was 




allowed for aortic outflow cannulation and atrial and ventricular apex inflow. A 
polyurethane aorta was connected to the ventricles that led to the systemic and coronary 
vasculature. The inertial effect was taken into consideration through the cross-sectional 
area and length of the tubing. The pressure-volume loop produced by the MFL represented 
a natural situation, and the MFL mimicked the Frank-Starling response for all conditions. 
The MFL also produced accurate hemodynamic waveform magnitudes and morphology 
for all conditions. Limitations of this study involved a lack of pulmonary vasculature and 
noise from the aortic pressure waveform. This MFL was later used by Glower et al.   and 
Koenig et al. [186] to evaluate artificial vasculature devices and investigate the 
hemodynamic and pressure-volume response to continuous and pulsatile VAD. 
Koenig et al. developed a systemic MFL to test continuous and pulsatile VAD. The 
hemodynamic and ventricular pressure-volume response was tested at different levels of 
assist for pulsatile and continuous flow devices. A mock ventricle was created in a hemi-
ellipsoid shape with a semi-rigid dome with the aortic and mitral valves mounts. The 
pressurized chamber controlled the system to obtain the required pressures and heart rate. 
A high-fidelity pressure-volume conductance catheter was used to monitor the ventricular 
pressure and volume. A compliant latex tube in a sealed chamber provided the resistance 
in the MFL. Pressure from the driveline was supplied to the ventricle and the sealed 
chamber to produce the required coronary flow. The limitation of the study involved the 
absence of pulmonary circulation.   
Litwak et al. [187] constructed an MFL with coronary vasculature. This MFL aimed to 
study the aorta outflow graft location with continuous and pulsatile flow VAD. The atrium 




placed in a pressure chamber. The apex of the ventricle achieved ventricular cannulation 
into the aorta. A coronary and systemic vasculature that includes the carotid artery was 
included. At the downstream of the MFL, the artificial aorta was connected into the mock 
vasculature. The accuracy of the cardiovascular simulation is improved by the inclusion of 
coronary circulation and carotid artery. As the pulmonary circulation did not exist, the 
venous return was ignored. A latex tube inside a pressure chamber mimicked the phasic 
coronary resistance. The same pressure pulse that drove the ventricle source was used. As 
a result, an elevated coronary resistance during the ventricular systole and reduced 
coronary resistance during diastole was seen. The above phenomenon resulted in a biphasic 
coronary waveform. 
Liu et al. [188] developed an MFL to test continuous-flow LVADs, as seen in Figure 14. 
Semi ellipsoidal-shaped silicone diaphragms used in pressure chambers mimicked the 
ventricles. For diastole, negative pressure was applied, and for systole, pulses of 
compressed air were sent to the chambers. Clear tygon tubing was used to connect all 
components, VAD was connected via the apex of the mock ventricle and systemic arterial 
tank. Check valves were used to achieve uni-directional flow. This MFL was sufficient to 
test LVADs under various conditions. An accurate prediction of LVAD performance could 





Figure 14 MFL by Liu et al. [188]  
 
Timms et al. [3] developed an MFL to test VADs. The aim was to develop a new MFL that 
could produce normal and heart failure conditions. The rig adhered to the Frank-Starling 
law, but the ventricular volume could not be measured. The MFL produced accurate data 
in terms of pressure and flow for normal and heart failure conditions. Limitations involved 
the use of heavy brass check valves, restriction of flow in the pulmonary circuit, and lack 
of measuring ventricular volume. 
Kozarski et al. [189] developed a hybrid MFL. This system uses features of present 
hydraulic and electrical models of the simulation. A flow generator was used to convert 
the incoming electrical signal into an appropriate flow for the hydraulic. The hydraulic 
component represented consists of characteristic arterial compliance, resistance, and 






There is a significant effect on the circulatory system due to the resistance to blood flow. 
The resistance R  increases as the radius r  of arteries and veins decreases. Resistance is 
also influenced by the length of the artery L and the viscosity of the blood  . Equation (2) 









A small pressure drop is seen when blood enters and exits the aorta, exhibiting very little 
resistance. Significant pressure drop on the blood is seen when blood enters the parts of the 
systemic circulation that includes smaller arteries and the arterioles as they provider higher 
resistance. By constricting or dilating the arteries, the body can change the resistance to 
flow. Dilation decreases the resistance causing more blood to flow to the artery, and 
constriction produces the opposite effect.  
SVR is defined as the resistance by the whole systemic circulation to the flow of blood. If 
the central venous pressure (CVP) is available. The value is usually assumed to be close to 










The value of resistance is obtained by a flexible tube in conjunction with a pinch valve. A 
variable level of resistance is obtained by lowering an electrical signal to occlude the 




Donovan et al. [166] provided an innovative technique in obtaining the resistance. Figure 
15 shows the mechanism used. Upon rotating the plate about a pivot to occlude the flow 
tube, the resistance of the pulmonary and systemic system was obtained. The value 
depended on the angle of rotation which was controlled by a lever arm. The lever arm is 
connected to bellows placed inside a chamber having water at a specific pressure. The 
bellows contract due to the pressure difference; this occurs when the aortic/pulmonary 
arterial chamber pressure increases. Due to this contraction, the valve plate is rotated about 
the pivot as the bellows are pulled on the lever arm. This makes the valve plate move, 
making the fluid flow through the flow tube due to a more cross-sectional area. This also 
lowers the resistance and lowers the arterial pressure. To obtain systemic resistance, an 
extra spring was used in parallel to the bellows to accommodate for the higher pressure.  
 
Figure 15 Resistance mechanism used by Donovan et al. [166]  
Trittenwein et al.[180] and Liu et al. [188] used sintered aluminum oxide porous blocks to 




resistance and impedance characteristics. The resistance value was adjusted by blocking 
unblocking the pores on the block; a moving sliding plate was used for this technique.  
Scotten et al. [176] used Equation (4)  and (5)  to represent the pressure drop and resistance  
















R is the resistance, Q is the volumetric flow rate, µ is the fluid viscosity, P is the pressure 
drop, and RL  RA are the effective length and area of the resistance tubing. Figure 16 shows 
the method to apply resistance by compressing small flexible tubes using a flat plate. A 
higher value of resistance is obtained as the magnitude of compression is increased. Ferrari 
obtained resistance by a slide that blocked the flow through a pipe when moved up and 
down. Resistance could be adjusted by choosing a value for the mean arterial pressure or 





Figure 16 Resistance segment used by Scotten et al. [176] 
 
Patel et al. [194]  used a 1.5-inch gate valve to obtain the resistance value. Resistance values 
for simulation of healthy were 0.85 . /mmHg s ml and for congestive heart failure was 1.2-
1.4 . /mmHg s ml .  
Pantalos et al. [185] obtained resistance for peripheral and proximal components by using 
a chamber that contains open cell foam with different densities. To adjust the value of 
resistance, the foam can be compressed by a sealed piston. 
2.2.2. Inductor 
The pulsatile nature of the blood requires constant change in motion when flowing through 
the circulatory system. On the mock loop, this can be represented by including an inertance 
component. This component can be achieved with the correct volume of fluid being flown 
in each section of the circulatory system and representing these values on the mock loop 




The Windkessel model models the circulatory system. The system represents features such 
as resistance, compliance, and inertance in the form of electrical drawings. Many mock 
loop simulations use arterial compliance C , characteristic resistance cR , and peripheral 
resistance pR for the three-element Windkessel model. A four-element Windkessel model 
includes an inertial component L . This is shown in Figure 17  
Stergiopulos et al. [195] reported that the inertance (Li) of a tapered wire can be represented 
















Where ls is the segmental length, ρ is the blood density; A is the cross-sectional area, and 
Cu is the coefficient considered for a non-flat velocity profile that equals 4/3 for low 
frequencies. Similar to spring constant, inertance in series and parallel are calculated. 
Inertance in series is the total sum of inertances and in parallel is shown in Equation (7) 
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Figure 17 Three and four element Windkessel model by Stergiopulos et al. [195] 
Noble et al. [196] conducted a study in dogs on the contribution of blood momentum to 




pressure transducers in the left ventricle and aorta. Controls noted and showed that the 
ventricular pressure was higher during the ejection period and an increase in aortic pressure 
above the ventricular pressure in the last 30-50% of the ejection. By placing an aortic 
occlusion device around the aorta, that required 20 ms to completely close, a spike in the 
ventricular pressure trace, and then a distant reduction in pressure. Results showed that 
blood momentum affects ejection.  
Scotten et al. [176] used Equations (8) and (9)  to solve inertance when the three-element 


















   
(9) 
 
P is the change in pressure,   is the inertance, Q is the volumetric flow rate, t  is time, 
 is the fluid density, 1L and 1A represent the length and cross-sectional area of the pipe. 
Stegiopulos et al. [195] aimed to find the difference between three and four-element 
Windkessel models in dogs, humans, and a mock loop. The main aim was to find the 
difference in pressure and flow measurements in the aortic section. The results obtained 
can be seen in Figure 18, which shows a significant difference in accuracy between the two 
models. The four-element Windkessel model presented a greater value of flow 





Figure 18 Comparison of measured aortic pressure trace vs three and four element windkessel 
simulations[195]. 
Ferreira et al. [197] conducted a study on 26 human patients to estimate arterial compliance 
using the three and four-element Windkessel model. Improved representation of the arterial 
compliance was better seen by adding the fourth element. 
2.2.3. Compliance  
The tendency of the blood vessel volume to increase as blood pressure increases is defined 
as Compliance [4]. Compliance is inversely related to stiffness, i.e., vessel walls stretch at 
a higher value of compliance. It can be expressed as shown in Equation (10) 
 Change in volume (ml)
Compliance =




Compliance of veins is approximately 24 times greater than that of arteries [4]. Hence veins 
can hold a large volume of blood when compared to arteries. Ventricle’s pressure-volume 




end-diastolic volume increases if the ventricle compliance is decreased. This is represented 
in Figure 19 
 
Figure 19 Effect of ventricular compliance [5] 
Donovan et al. trapped the air volume in each chamber above the circulatory fluid to obtain 
compliance.  
Garrison et al. [198] designed a mock loop for hemolysis studies associated with VADs. 
Two 70ml sacs and a sealed chamber were used as the compliance chamber. The chamber 
designed was large to fit one full and empty sac inside. The chamber limiting volume 
changes, hence compliance. This feature was used for aortic and venous compliance.  
Marcus et al. [199] conducted a study on healthy patients. The aim was to determine the 
arterial compliance and compare it with the two and three-element Windkessel model. The 
hemodynamic profile of the population is mentioned. 
Woodruff et al. [200] performed studies on cardiac performance in microgravity using a 
compact mock loop. The Penn State mock loop was chosen as the base, and the weight of 




reduce size and weight. To accommodate many different spring diameters and to center the 
spring, a conical seat is used. Target values for arterial and venous compliance were 1 and 
10 /ml mmHg . Spring values were chosen at 5, 10, 15 /ml mmHg for venous compliance 
and 0.5, 1, and 1.5 /ml mmHg  for arterial compliance. Limitations in this study included 
changing springs for each variation in compliance that resulted in inefficient testing 
procedure, and approximations were made for the desired spring constants and their 
corresponding compliance values. The weight and volume of the new design were 47% 
and 64% lower compared to the Penn State design. 
 
Figure 20 Compact spring compliance chamber by Woodruff et al. [200] 
 
Arabia et al. [201] ,Figure 21,  Ferrari et al. [202] used a spring capacitor to obtain 
compliance. Arabia et al.  used 3.6, 4.8, 82.5, and 10 /ml mmHg  as compliance values for 




al. [185] used the concept of spring for compliance. The required amount of compliance 
was obtained by using a spring-loaded piston on a roll sock diaphragm. 
Kolh et al. [203] studied the effect of the increase in aortic compliance on ventricular 
performance. The aim was to investigate the energetic cost of cardiac ejection and left 
ventricular contractility when aortic compliance applied was increased. The results 
obtained in this study showed that the effect of increasing aortic compliance had a 
significant reduction in the energetic cost of the heart, and the effect on the contractile 
function was minimal.   
 
Figure 21 Spring compliance chamber by Arabia et al.[201 .  
Lick et al. [204] adjusted the compliance chamber to further a previous study on an artificial 
lung. Previous in vivo studies of an artificial lung produced a 50% right heart failure 
immediately causing death. Initial designs were modified by including an inflow 
compliance chamber, inflow separator, and modified outlet geometry. A solvent cast, 
polyurethane, was included in the method to obtain the compliance chamber. Pressures 




encased in open-faced housing. Significant improvement in results was noted in the new 
in vivo trials. 
Dumont et al. [190] developed a pulsatile bioreactor for the tissue engineering of an aortic 
valve. The system used variable compliance, where the air pressure above the water inside 
the chamber was altered. This design would give variable compliance under the assumption 
that change in volume due to change in pressure is negligible. The mock loop only 
represented systemic circulation and lacked pulmonary circulation. As the pressure 
changes in the whole system due to varying compliance, this concept of a compliance 
chamber is not suitable for full mock circulation. A value of 0.4-1.2 /ml mmHg  was used 
for compliance. 
Papaioannou et al. [205] conducted a study on the effect of arterial compliance on the 
effectiveness of intra-aortic balloon counterpulsation. Windkessel chamber with a variable 
air volume was used to simulate the compliance. The isothermic air process assumed by
PV constant , giving rise to the formula for compliance as /C V P . Varying the 
compliance between 1.05-2.62 /ml mmHg , the heart rate was between 80, 100, 120 bpm , 
and the mean aortic pressure was 55, 75, and 105 mmHg . Results showed that arterial 
compliance is a significant factor that influenced the performance of intra-aortic balloons. 
Left ventricle stroke volume increased by 6% for systolic dysfunction when the arterial 
compliance was increased. No change was seen for diastolic dysfunction.  
Bustamente et al. [191]  created a compliance chamber using a flexible rubber wall. The 
chamber was primarily clear plastic. A flexible rubber diaphragm was used on one wall to 




material having a different stiffness if the compliance needed to be changed. Using the 
flexible rubber, positive results were recorded.  
Haft et al. [206] developed an artificial lung compliance chamber. The mock loop model 
did not include the inertance and adjustable resistance element but relied on the tubing 
resistance and pulsatile flow VAD. Constant pressure was delivered into the VAD, which 
delivered fluid to the compliance chamber; Figure 22 shows the compliance chamber made 
from a flaccid polyurethane bag in an airtight box that receives compressed air to alter the 
compliant nature of the bag. External pressure applied to the compliance element 
maximized the value of compliance and altered its time scale by augmenting diastolic 
emptying and before systole maximize the capacitance.  
 
Figure 22 Compliance element used by Haft et al. [206] 
Fiore et al.[183] The arterial compliance is used as part of the hydraulic side of the hybrid 
system. This reduced the effect of mechanical and hydrodynamic disturbances and 
improved the quality of pressure measurement. The value selected for the compliance was 
1.2 /ml mmHg . Additional arterial compliance was added to the electrical circuit; altering 
the arterial compliance can obtain a variable compliance value. Loh et al. [214] chose the 




The values for aortic and left ventricular compliance are higher compared to the other 
literature. Airtight tanks with a trapped volume of air above the fluid were chosen for 
compliance mechanism.[187],[188],[206], [207] [208] . Variable levels of compliance 
[209] [210] [211] [212] [213] [214] [215] [216] [217] [218] are produced continuously by 
these chambers. The mock loop requires a shutdown for each compliance change. Litwak 
et al. used 43.6, 4.9, and 5.6  L  as volumes for systemic venous, systemic arterial, and 
pulmonary compliances. The volume of air is altered by incorporating an air valve. 
Equation (11) was used to compute the compliance 
 fluid air tank tank fluid
fluid air fluid fluid
dV V V -A .h
C= = =
dP P P -ρ.g.h
 
(11) 
C corresponds to compliance airV and airP are the volume and pressure (absolute) of air in 
the tank and the tank's volume and cross-sectional area. fluidP and fluidh are the pressure 
(absolute) and height of the fluid.  is the density of the fluid and g is the acceleration due 
to gravity.  
Hassani et al. [219] developed a mathematical model to study aortic aneurysms. 
Compliance, inertance, and resistance were included in the model. Equation (12) was used 
to compute the compliance of an elastic vessel.  









C  is the compliance, R is the radius of the vessel, Z is the length of the vessel, h the 
thickness of the vessel, and e the elastic modulus of the vessel.  
Timms et al. a [3]trial compliance was achieved by using an open to air chamber that 




height of the fluid and hence changing the level of compliance. Using the fluid-filled 
chamber with a trapped air method, the aortic, systemic vascular, and pulmonary arterial 
and pulmonary vascular compliance was used.  
Stergiopulos et al. [220]study was conducted into current methods to estimate the arterial 
compliance and compared the results with the previously developed mathematical model, 
including 55 arterial segments modeling the major arteries. Fluid inertia, fluid friction, and 
nonlinear compliance were considered for this model. Three three-element Windkessel 
methods were analyzed using various methods, and Four two-element Windkessel was 
employed, including the area method, two-area method, and the integral method. All 
methods based on the two-element Windkessel produced less than 10% errors than the 
three-element Windkessle model. It was concluded that the three-element Windkeseel 
model could be used to represent the arterial system accurately. The two-element 
Windkessel model represents the systemic arterial tree at low frequencies. 
Segers et al. [221] concluded that the pulse pressure method was consistent for estimating 
total arterial compliance. The in vivo results of the pulse pressure method are compared 
with stroke volume: pulse pressure ratio and the area method. 
 
2.3. Summary 
The three-stage palliative procedure is a series of surgical procedures to treat the HLHS 
anomaly in neonates. Stage I involves the Norwood procedure, where the surgical 
procedure aims to provide an unrestrictive systemic blood flow while balancing the 
pulmonary flow. Stage II involves the Bi-directional Glenn/ comprehensive stage II, and 




pressure pulmonary flow. The BDG procedure involves removing mBT shunt and 
dissection of SVC from the right atrium and anastomosed to Right Pulmonary Artery 
(RPA). The comprehensive stage II is an alternative to BDG. Similar physiology is 
established between comprehensive stage II and the Glenn procedure. An in-depth literature 
survey is conducted towards the in-vitro and in-vivo simulations to address complications after 
the BDG and comprehensive stage II procedure. 
Complications involve unilateral pulmonary artery stenosis. An alternate approach is also 
known as the Assisted Bi-directional Glenn surgical procedure, is also discussed. A novel 
surgical technique to the comprehensive stage II has been discussed in the literature to reduce 
surgical trauma in patients. The HCSII procedure reduces the surgical trauma and avoids 
creating aortic arch reconstruction and Damus-Kyle Stansel (DKS) connection. The HCSII 
procedure applies to patients with sufficient antegrade aortic flow to sustain upper body 
perfusion. Stage III involves the Fontan procedure; this procedure aims to connect the 
systemic and pulmonary circulations in series. An in-depth literature study focuses on extra 
cardiac Fontan operation and PVR. To improve the efficacy of the stage III procedure, a 






3.1. Anatomical model 
3.1.1. HCSII 
Arnold Palmer Children’s Hospital provided the patient-specific angiogram data to develop 
the phantom for in-vitro simulation. Figure 23 A and B represents the native ascending 
aorta, right subclavian artery (RSA), right carotid artery (RCA), left subclavian artery 
(LSA), and left carotid artery (LCA). The diameters of the native ascending aorta, RSA, 
RCA, LSA, and LCA were 9.96 mm , 4.53 mm ,4.53 mm , 5.75 mm , 4.36 mm . The lengths 
of the native ascending aorta and LSA and LCA combined length was 29.19 mm , 13.21 
mm . Figure 23 C and D represent the Glenn procedure performed. Figure 24 A, B, C, D 
represents the aortic root and its dimensions.  The main pulmonary artery (MPA) root, the 
aortic arch, and the descending aorta having diameters of 22.67 mm , 8.26 mm  (averaged), 
and 9.88 mm . The lengths of the MPA root, the aortic arch, and the descending aorta were 
20.68 mm , 20.59 mm , and 43.06 mm . DeCampli et al. mention that the hybrid 
comprehensive stage II technique avoids creating Damus-Kyle-Stansel (DKS) connection 
and aortic arch reconstruction. The HCS II procedure also involves suturing of baffle using 
a pulmonary homograft material within the pulmonary bifurcation from the right to the 
LPA orifice. By preserving every eigen feature of the physiology, the phantom was 
designed to validate the clinical study conducted by performing in-vitro simulations. The 







Figure 23 Angiogram data of three de-identified patients provided by Arnold Palmer 
Children’s Hospital  
 




The development of the centerpiece is a two-part process; the top half contains all the 
conduits designed based on the angiogram data. The conduits in the phantom represent the 
diminutive aorta, MPA, LPA, and RPA. Since the RSA, RCA, LSA, and LCA diameters 
are lower than other sections, a single conduit was designed to represent the upper 
circulation. The diameter of this conduit is the summation of RSA, RCA, LSA, and LCA 
diameters. Following the physiological procedure, the phantom is designed without the 
patent ductus arteriosus, DKS connection, and the native aortic arch remains natural. The 
region corresponding to the patent ductus arteriosus is stenosed. The main constrain to be 
followed during the design stage was no baffle movement and the stent. An elliptical 
section was designed on the MPA to place the baffle; the stent below the baffle. To 
integrate the centerpiece with the MFL, barbed conduits are designed at six locations. The 
pressure sensors are placed over the barbed conduits to obtain the phantom's hemodynamic 
parameters for each heart cycle during in-vitro simulations. The bottom half of the 
centerpiece covers the pulmonary arteries once the baffle and the stent are placed in their 
respective locations. The top and the bottom half of the phantom were designed using 
CATIAv.5 (Dassault Systèmes). Figure 25 shows the development of a 3D CAD model 





Figure 25 Development of 3D CAD model of HCSII centerpiece from angiogram A. 
Diameter of RCA, RSA, LCA and LSA B. Diameter of MPA root C. 3D CAD model on 
CATIAv.5 D. Diameters of the aortic arch and descending aorta E. Diameter of 




Figure 26 3D phantom printed with the conduits 




In Figure 26, section 1 represents the flow towards the upper body. Section 2 and section 
6 are connected together to form the PA (pulmonary artery). Section 3 forms ascending 
aort, section 4 forms main pulmonary artery and section 5 forms descending aorta in the 
3-D phantom.    
3.1.1.1. Initial Design  
To increase the rigidity of the phantom, a rectangular block was added to the top half. 
Figure 27 shows the initial design of the centerpiece with the rectangular block. Figure 27 
A represents the native aorta being stenosed. Figure 27 B represents the front view of the 
centerpiece along with the rectangular block. Figure 27 C represents the interior view of 
the top half with the baffle location. Figure 27 D represents the side view featuring the 





Figure 27 Design 1 of the top half of the centerpiece A. Ascending aorta is stenosed B. 
HCS II centerpiece within the rectangular block C. Interior view of the centerpiece with 
rails D. Side view of the top half  
The bottom half of the phantom was designed for easy accessibility of baffle and stent. The 
bottom half was machined using acrylic, as seen in Figure 28 A. Lasers were used to 
illuminate the characteristic features of the stent. To accommodate the addition of the laser, 
three slots of equal diameter at an equidistant were extruded. To avoid stent migration 
during in-vitro simulation, two equal diameter stubs at an equidistant were extruded. The 
laser slots and stent stopper feature are represented in Figure 28 B. Two slots of equal 
diameter were created at the opposite ends, and extruded cut was performed at an angle as 
shown in Figure 28 C to capture the stent and baffle's movement using a camera.  
 
Figure 28 Design 1 of the bottom half of the centerpiece A. Bottom half of centerpiece 
with stent stopper and slots for laser C. Slots to place the camera 
 
Two sets of rails were designed to reduce the slipping that could occur between the top and 
bottom half and integrate both halves. The top and bottom half of the phantom went through 
two iterative design changes. The initial prototype could not maintain the flow separation 
between the pulmonary trunk and the pulmonary arteries. The barbed ends broke as they 
could not sustain loads of the connectors used. Leakage was visible during the 




3.1.1.2. Design Iteration 1  
The first iteration does not involve any changes to the conduits that represent the 
physiological condition. Figure 29 A shows changes made to the bottom half of the 
phantom to place an otoscope. To follow the exact procedure mentioned by DeCampli et 
al.  [115] for the baffle, a clip was designed to constrain the baffle movement; the clip is 
placed onto the top half of the phantom, as seen in Figure 29 C. The railings designed to 
ease the mating were removed, as seen in Figure 29 D. 
 
Figure 29 Design iteration 1 for top and bottom half of the centerpiece A. Changes made 
to the machined part with a slot for otoscope B. View of the centerpiece. C. Clamp 





3.1.1.3. Design Iteration 2 
The second iteration involved considerable changes to the top half of the phantom. In this 
design, the rectangular block was increased in length and breadth, as seen in Figure 30 A. 
The barbed connectors protruding outside were removed, as seen in Figure 30 B. A step 
cut feature was developed on the bottom half of the phantom. Figure 30 C shows the step 
cut design such that the specula of the camera would touch the bottom to focus on a specific 
area of the stent. 
 
Figure 30 Design iteration 2 for top and bottom half of the centerpiece A. Interior view of 
the top half and B. Front view of the top half  C. Back view with the square slot 
 
3.1.1.4. Final Design  
The final design of the phantom involves the modifications that were carried out in the 
design iteration process 2. Extra layers on the bottom half were removed from the previous 
design, and a layer of a gasket was added to avoid leaks, as seen in Figure 31 A. A through-
hole feature was developed on the top half for the extended length, as seen in Figure 31 C. 
To accommodate commercially available barb connectors to integrate the phantom with 
the MFL, threading operations were performed on the remaining circular slots on the 
centerpiece. Figure 32 A represents the 3D printed centerpiece. Figure 32 B represents the 




C represents the bottom half of the centerpiece with stent and gasket. Figure 32 D 
represents the machined backplate with two slots extruded for laser slots.   
 
Figure 31 Final design of centerpiece A. Gasket B. Front view of the top half of 





Figure 32 3D printed and machined centerpiece A. HSCII centerpiece B. The top half of 
centerpiece with baffle C. Bottom half of centerpiece with stent and gasket D. machined 
backplate  
 
3.1.2. Fontan IJS  
The in vitro study was modeled to validate the in-silico simulation of the Fontan patient 
[222]. modeled the baseline TCPC on SolidWorks (Dassault Systèmes) using an averaged 
dimensions of 2-4-year-old Fontan patient. Four models’  configurations were developed, 
including the baseline, IJS, NES, and IJS with pulmonary artery radius increase. To 
accommodate the increase in the pulmonary flow, the cross-sectional flow area of the 









. Keeping the 
correlation of the in-silico model, the 3D phantom was developed. The process involved 




The TCPC was developed by calculating the diameters of RPA, LPA, SVC, and IVC as 6 
mm , 9 mm , 12 mm , and 18 mm . Their corresponding lengths of RPA and LPA were 40 
mm  and for SVC and IVC were 23 mm and 56 mm . A two-part process was carried out to 
develop the top and the bottom half. The TCPC was developed using Acrylonitrile 
butadiene styrene (ABS) and manufactured by 3D printing technology. Post 
manufacturing, the top and bottom half are joined together using a sealant. The ends of the 
TCPC are clamped when connected to the MFL. 
The IJS was developed in three pairs having an internal diameter of 2 mm , 3 mm , and 
4mm. The nozzle is placed on top of a coupler with a total length of 135.7 mm . The 
diameter at the center section is 20 mm  at the center and 9 mm  at the ends. The IJS is 
intruded into the LPA and RPA, and the nozzle orient parallels to the flow direction. The 
role of IJS is to introduce an entrainment jet that flows concentrically to the pulmonary 
artery flow. The entrainment jet exchanges momentum with the flow in the pulmonary 
arteries, decreasing the localized vascular resistance in TCPC and decreasing the IVC 
pressure. Figure 33 shows the 2D drawing of various IJS developed along with the 3D 
printed prototypes.  To ensure the concentricity of the flow, the diameter of the IJS 
increases at the entrainment point. The cross-sectional area of the conduits is increased to 
accommodate the excess flow and reduce the flow momentum effect. The IJS was coated 





Figure 33 2D drawing of 2mm, 3mm, and 4mm IJS (L), 3D printed IJS prototype  
3.1.2.1. Fontan model version 1 
The in vitro study was modeled to validate the in-silico simulation of the Fontan patient. 
The in-silico study involves patients' anatomies within 2-5 years of age, with a BSA of 0.7
2m . The traditional Fontan procedure with fenestration is considered as the baseline for 
the in-vitro study. The fenestrated 2Y graft TCPC connection with the proposed IJS at IVC 
is another development. The fenestration having a diameter of 4.75 mm and length of 17.5 
mm  is located at the bifurcation of the Fontan conduit. The fenestration contributes to the 
IVC pressure drop. In the proposed model, the IJS is designed to be collinear with the 
fenestration. The excess fluid being injected is captured by the fenestration, thereby 
enhancing the entrainment. Systemic oxygen saturation remains as part of the IJS flow 
absorbed in the fenestration. Figure 34 A. represents the elliptical profile. Figure 34 B. 
represents the IJS shunt. Figure 34 C. represents the diamond profile, and Figure 34 D. 




The first iteration involves the development of TCPC using acrylic that was machined. A 
two-part process was performed to carry out the manufacturing process. The TCPC was 
modeled at a length, width, and thickness of 196 mm , 171 mm , and 34 mm . The diameters 
of conduits for SVC and LPA were 11 mm , 9 mm  for RPA, and 18 mm  for IVC. A plane 
along the LPA-RPA dissects the centerpiece into two parts. To integrate the TCPC 
centerpiece with the MFL, four aluminum adapters of length 76 mm , width 25 mm , and 
32 mm  thick were machined.    
 
Figure 34 2mm IJS shunt A. elliptical profile B. Side view of the IJS shunt C. Diamond profile D. 
Circular profile  
 
3.1.2.2. Fontan model version 2 
The second version involves the development of TCPC along with the IJS as a two-part 
process. The fenestrated 2Y graft TCPC Fontan geometry was 3D printed by preserving 




conduits that represent the 2Y are simplified to a single conduit. The diameters of SVC, 
LPA, and RPA are 12.7 mm , and IVC diameter is 19.05 mm . The TCPC is split into two 
blocks. The top block contains the conduits representing the SVC, LPA, RPA, and fraction 
of IVC conduit. The fenestration is developed at the bifurcation of the Fontan conduit.  
A parametric study is being conducted on the different IJS types that could yield the 
optimum pressure drop across the IVC. Four versions of the bottom blocks have currently 
been developed that house the IJS. The versions are classified based on the shape and 
number of the nozzles. The IJS nozzles are conically tapered and chamfered at the outlet 
section and are collinear to the fenestration. Threaded bolts are used on the either side of 
the IVC to integrate the top and bottom block. A lip with a compression fitting gasket is 
implemented into the design to provide a tight fit. 
Figure 35 shows a 2D model of the 2Y TCPC. Figure 35 A shows the side view 
representing the lip section's dimensions for compression and the dimension related to the 
IJS. Figure 35 B represents the front view of the TCPC centerpiece and the dimensions of 
the top and bottom block. Figure 35 C represents the interior view of the bottom block 





Figure 35 A Side view representing lip section and IJS dimension B. TCPC front view C. Interior 
view of the bottom block with two circular profiles of the IJS nozzle  
Figure 36 A represents the side view of the centerpiece Figure 36 B represents the front 
view of the TCPC centerpiece and the lengths of SVC, IVC, RPA, and LPA. Figure 36 C 
represents the interior view of the bottom block showing the two elliptical profiles of the 





Figure 36 A. Side view of the TCPC B. TCPC front view with the length of the conduits C. 
Interior view of the bottom block with two elliptical profiles of the IJS nozzle  
Figure 37 A represents the interior view of the bottom block showing a single circular 
profile of the IJS nozzle having a diameter of 2 mm . Figure 37 B shows the front view of 
the TCPC and the diameters of SVC, IVC, LPA, and RPA.  
 
Figure 37 A. Interior view of the bottom block with one circular profile of the IJS nozzle B. Front 





Figure 38 A represents the side view of the centerpiece and the dimensions of the IJS 
leading to the fenestration. Figure 38 B represents the front view of the centerpiece and the 
dimensions of rectangular fittings designed to integrate the centerpiece with the MFL. 
Figure 38 C represents the bottom block's interior view showing the IJS nozzle's one 
elliptical profile. 
 
Figure 38 A Side view of TCPC with IJS at fenestration site B. Front view of TCPC with adapters 




3.2. Lumped Parameter Model  
As described in section 2.2, the LPM is an electric analogy used to replicate the circulatory 
system of human circulation. Using this electric analogy, blood flow through various 
sections in the cardiovascular system can be lumped and represented as electrical circuits 
that include resistors, inductors, and capacitors. Each of these elements represents vascular 
resistance, vascular inertance, and vascular compliance. As discussed in section  2.2, 
different LPM setups have been modeled to experimentally replicate various reconstructed 
cardiovascular physiologies in the last few decades. The main goal of the LPM setup is to 
couple the fluid dynamic behavior within the 3D phantom to the dynamics of the peripheral 
circulation.  
To achieve the research objectives established in each problem statement, a specific LPM 
has been modeled to replicate the proposed reconstructed physiology. Ideally, a 
Windkessel compartment in the LPM consists of an arterial bed and venous bed. The 
arterial bed is developed using an inductor, resistor, and capacitor, while the venous bed is 
developed using the resistor and capacitor. In our experimental studies, each Windkessel 
compartment is modeled by lumping the arterial and venous beds together, as shown in 






Figure 39 Lumped Arterial and Venous bed coupled for LPM development 
In this study, reduced-order LPMs have been modeled to develop both MFL setups. 
Hence it is sufficient to control the correct overall resistance and compliance in each 
branch of the system.  
Vascular resistance: 
Inlet and outlet pressures are tuned in the MFL. These inlet and outlet pressures generate 
the pressure differential. This static pressure differential causes the flow to occur in the 
system. The conduits in the MFL provide a certain amount of resistance, but additional 
resistance is provided to the system by valves. As discussed in 2.2.1, resistance in a fluid 
circuit is defined in (4)  by Scotten et al. [176]. The pressure drop across each branch is 
achieved by tuning the resistance in the conduits of MFL. As a result, the blood analog 
will flow through each conduit across this pressure drop in the MFL setups. In this study, 
resistance in each conduit of the MFL is achieved by placing a needle valve. Resistances 










   
(13) 
 
where  h is defined head loss, K  is the loss coefficient that is dictated by the position of 
the valve, V is the average velocity of the fluid, g is the gravitational constant.  
The needle valve resistors are manually actuated and precise. These resistors have a range 
of seven color bands, and each color band has a setting ranging from 0-9, as shown in 
Figure 40. The pressure drop produced across the needle valves is linear that majorly 
contributes to the successful tuning of the MFL rigs.   
 





Inductors affect only non-steady systems. In fluids, inertance is defined as the pressure 
gradient to accelerate the flow. It is a parameter that describes how rapidly pressure field 









In both of the discussed MFL setups, the inertance is captured by the length of the 
vasculature. A specific length for each vasculature cannot be modeled as the arteries and 
venous network of a human circulation are extremely long. 
Vascular Compliance: 
In biofluid mechanics, vascular compliance refers to the change in stored energy in a vessel 
for a given change in pressure in the time domain. It is entirely analogous to capacitance 
in electrical circuits. Like an inductor, this parameter does not affect the behavior of a 
steady system. This parameter is critical in accurately modeling the effects of distensibility 
of the arterial and venous beds in MFL, as described in Equation (10) from section 2.2.3. 
Specific annular design-based compliance chambers have been developed to produce the 
desired compliance (C) in this study. These compliance chambers are capable of matching 
specific compliance in a Windkessel bed by altering the volume of the chambers for a 
change in dynamic pressure of the fluid generated across that chamber in the MFL. In this 
setup, a pair of concentric tubes were used to create the annular inner section of the 
compliance chamber. The outer tube of the compliance chamber was constructed using the 
clear schedule 40 and 80 pipes, and the inner wall is constructed by using solid Delrin rods, 





Figure 41 Design of annular compliance chamber replicating the vascular compliances.  
To obtain the effective radius, the outer diameter of the compliance chamber was constant 
while the inner diameter varied for simulating different patient-specific cases. Using this 
volume-controllable approach, no parameter such as entrapped pressure changes during an 
MFL run reduces the uncertainty of the analysis. The Equations (15)-(17) show 
relationships between the pressure and volume of the compliance chamber with the 
effective radius,   
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To achieve the desired compliance value for the vascular compliance elements, the above 
equation can be modified to describe the compliance as a function of the 



























Where re is the effective radius of the cylindrical compliance chamber.  
In the following subsections 3.2.1 and 3.2.2, the construction of LPM  for HCSII and 




3.2.1. Lumped Parameter Model for HCSII 
 
Figure 42 LPM representation of HCSII 
As described above in 3.2, a complex circulatory system can be reduced to its equivalent 
mathematical circuit for analysis using the lumped parameter modeling technique.   
The reduced LPM used in this study derived from the full-scale LPM model of Hameed et 
al. [224] The full-scale LPM is not practically feasible in a laboratory benchtop realization. 
Tuning such an MFL with a full-scale LPM circuit would be difficult. Furthermore, the 
number of elements requiring connectors and tubing would create too much inertance. The 
full-scale LPM is reduced to a branched LPM of equivalent impedance to create a 
practically feasible system. In-vitro study on HCSII circulation was conducted through a 
dynamically scaled Mock Flow Loop (MFL) using patient-specific geometry. The MFL 
was modeled to resemble the physiological anatomy of a patient with 0.34 2m BSA. In this 
MFL setup, the lumped compartments representing the peripheral circulations of the 




four compartments, and each compartment is developed with two elemental (i.e., resistance 
and compliance) Windkessel models. Four compartments represent upper systemic, lower 
systemic, right, and left pulmonary circulations, as shown in Figure 42. Each lump 
represents the arterial and venous vasculature found within the physiological anatomy. The 
voltage source represents the right ventricle. The ventricular septal defect (VSD) is not 
modeled in the 3-D phantom but is represented in the LPM circuit. To replicate the VSD, 
two resistor valves are placed between the bifurcation junction (upstream of the right 
ventricle) and the inlet of the MPA and Asc. Aorta in the 3-D phantom. This study focuses 
on the flowfield developed in the HCSII geometry; hence, the BDG section is in the LPM 
circuit as shown in Figure 42. Every branch in the reduced LPM contains circuit elements 
that correspond with a device in the MFL that serves as a physical realization of that 
parameter. Table 2 Compliance values for MFL represent the compliance values 
considered in each lump while conducting the experimental study. 
Table 2 Compliance values for MFL 
Compliance sections in 
MFL 
Compliance Value  
 /ml mmHg
 




















3.2.2. Lumped Parameter for Fontan 
   
Figure 43 LPM representation of Fontan 
 
Ni. et al. have developed a detailed full-scale LPM of Fontan circulation. This LPM 
consists of carotid, subclavian, right pulmonary, left pulmonary, lower body, Fontan 
TCPC, and coronary compartments. Each compartment contains an arterial and venous 
bed. In this full-scale LPM model, every arterial bed is modeled with a three-element 
Windkessel model. As discussed in the above paragraph 3.2.1, a laboratory benchtop 
realization based on full-scale LPM  is not practically feasible. Hence the MFL setup for 
the Fontan circulation involved in this study is based on a reduced-order LPM derived from 
Ni. et al. . The hydrodynamic variables measured in this study are the systemic arterial 
pressure, the flow rates in arterial and venous branches, the pressures and flow rates at the 
location of the Fontan connection, and the pressure at the end of the system in the atrium. 




mentioned in section 3.2, every compartment of this model is developed with two elements 
i.e., resistance and capacitance, as shown in Figure 43. This LPM has two systemic and 
two pulmonary compartments. Two systemic compartments represent upper and lower 
systemic circulations, and two pulmonary compartments represent right and left pulmonary 
circulations, respectively. Each branch in the MFL contains a device that corresponds to a 
circuit element of the reduced LPM. As mentioned in section 1.2, pulsatility plays a crucial 
role in the hemodynamic behavior on the arterial side. Also, the arterial network and 
capillary system of the systemic circulation provide significant vascular reistance and 
vascular compliance to the flow field.  These arterial networks act as low pass filters to the 
pulsatile flowfield and effectively dampens out most of the pulsatility in the blood flow by 
the time it reaches the TCPC. Furthermore, the Fontan circulation is especially less 
pulsatile on the venous side due to the absence of the ventricle. In this study, the remaining 
pulsatility from the cardiac cycle is not modeled. To accurately replicate the infant anatomy 
while conducting the Fontan experiment, the values of compliance were determined based 
on physiological values that correspond to body surface area (BSA) of 1.2 2m .defined in 
[64]  
Table 3 shows the values of vascular compliances corresponding to different anatomical 
sections. 





Upper compliance (Cupper) 
 
TCPC compliance (CTCPC) 
 
IVC compliance (CIVC) 
 
Liver compliance (Cliver) 
 
Lower compliance (Clb) 
 
Right compliance (Cright) 
 
Left compliance (Cleft) 






4.41 ± 0.03 
 






Due to the relative similarity between the IJS Fontan Mock Flow Loop used in this 
experiment and the reduced lumped parameter network model utilized in, all but the 
lower systemic compliance could be carried over. To calculate the lower systemic 
















Therefore, the resulting compliance values used in this experiment are given below in  
Table 4 





Vascular Compliance  




Cupper, Upper Systemic 3.12 0.3365 
Clower, Lower Systemic 3.86 0.3742 
Cleft, Left Pulmonary Artery 2.14 0.2787 
Cright, Right Pulmonary Artery 2.14 0.2787 
 
3.3. PVR 
Pulmonary vascular resistance (PVR) is an essential hemodynamic quantity that is very 
indicative of Fontan surgeries' outcomes. Abnormal growth of the pulmonary vasculature 
and significant collateral flow can significantly alter PVR, leading to cardiovascular 
malfunctions. In particular, elevated PVR can cause pulmonary hypertension, which 
strongly affects the Fontan patient’s wellbeing. Several studies point to the possibility of a 
strong correlation between pulmonary flow and PVR . The study attempts to quantify 
changes in PVR between rest and exercise conditions induced by dobutamine 
administration, which directly affects the heart rate and stroke volume. The data reveals 
a negative correlation whereby an increase in pulmonary flow induces a drop in PVR.  
This observation becomes of particular importance for our study as implementing an IJS 
significantly enhances pulmonary flow. In the absence of any PVR response, the additional 
flow would cause an increase in IVC pressure; however, if PVR decrease could be 
considered, the additional flow would not build up in the Fontan circulation. A PVR drop 




be directly responsible for additional pressure reduction. With the accommodation of the 
IJS flow, if flow entrainment occurs, the IJS can directly cause a significant pressure drop.  
Based on the data presented by Schmitt et al. [150] it is possible to derive a curve relating 
the percent change is PVR with the percent change is pulmonary flow. Out of the ten 
patients presented in the study, two were considered non-responders as the PVR hardly 
changed following dobutamine administration although the observed flowrates reacted 
accordingly. Due to the low population in this study the resulting statistical analysis an 
accurate trend cannot be extracted, but nonetheless, it can be observed. As shown in Figure 
44, for an increasing 𝑄𝑃 the PVR does in fact drop.  
 
Figure 44 Correlation for percent PVR change too percent pulmonary flow change 
  
The plot suggests that the PVR percent change lies in the region of 30−40% for a 
maximum. This study will use these results to sequentially drop PVR following IJS 
activation to observe what happens to the IVC pressure. This study will use these results 





3.3.1. Pulmonary Vascular Resistance Calibration  
The relationship between flow rate and needle valve resistance must be determined to 
implement the PVR drop to increase pulmonary flow. To evaluate the pulmonary 
resistances, a simple flow loop is set up with a continuous flow pump. The needle valve 
resistance is calculated by measuring the pressure upstream and downstream of the valve 
in conjunction with the flow rate Figure 45. Ohm’s law relates the scalar valve resistance 
to the mean pressure gradient ratio to the flow rate. All the valve settings are tested for 
three flow rates 1.45 
min
L , 1.75 
min
L  , and 2 
min
L . The calibration procedure is carried 
out on the right and left pulmonary resistances. Figure 45 B presents the most significant 
range of valve settings tested for calibration. The curve shows that for the same valve 
setting but incremental flow rates , the valve resistance grows. This becomes more evident 
for more restricting valve settings (green to blue).  
 
Figure 45 A. Resistance calibration loop and  B  calibration curves for pulmonary resistances for 




3.4. PVR and entrainment quantification  
The drop in PVR may be considered a concomitant effect as the fluid is injected into the 
Fontan conduits. There is a scarcity of studies to relate this phenomenon; hence pediatric 
interventionists from the Arnold Palmer Children Hospital proposed a protocol to quantify 
this effect in both in-vitro and in-vivo studies. This experiment is independent compared 
to the IJS in the Fontan study but will support IJS placement in PAs. The efficacy of the 
experiment, i.e., to study the variation in hemodynamic parameters when injections push 
the fluid into the PAs, is obtained through this in vivo study. A keen interest is shown 
towards the coronary effect that could arise during this process.  
Table 5 shows the protocol provided by the pediatric interventionist. The protocol was 
developed based on the instantaneous p
Q
Qs
equal of 1.5 with the injections and the cardiac 
output of 2.5 /L min . The protocols are divided based on short multiple injections and 
single long injections. The short multiple injections were further subdivided into five bursts 
and ten bursts. The flow rate of the injection fluid was classified into 5 /cc s , 10 /cc s , 15 
/cc s  , and 20 /cc s . The total volume of the fluid injected depends on the number of 
bursts and volume injected during each burst. For this experiment, the volume for each 
burst was classified into 20 cc ,15 cc ,10 cc  , and 5 cc .   
Table 5 Injection protocols provided by clinicians at Arnold Palmer Hospital 
Type of injection Flowrate 
( /cc s ) 
Total volume ( cc ) 
Short multiple injection 5 520cc injections (100 cc total volume) 
  515cc injections (75 cc total volume) 




  105cc injections (50cc total volume) 
 10 520cc injections (100 cc total volume) 
  515cc injections (75 cc total volume) 
  1010cc injections (100cc total volume) 
  105cc injections (50cc total volume)  
 15 520cc injections (100 cc total volume) 
  515cc injections (75 cc total volume) 
  1010cc injections (100cc total volume) 
  105cc injections (50cc total volume)  
 20 520cc injections (100 cc total volume) 
  515cc injections (75 cc total volume) 
  1010cc injections (100cc total volume) 
  105cc injections (50cc total volume)  
Long single injection 5 150cc injection (50cc total volume) 
  1100cc injections (100cc total volume) 
  1150cc injections (150cc total volume) 
 10 150cc injection (50cc total volume) 
  1100cc injections (100cc total volume) 
  1150cc injections (150cc total volume) 
 15 150cc injection (50cc total volume) 
  1100cc injections (100cc total volume) 
  1150cc injections (150cc total volume) 
 20 150cc injection (50cc total volume) 




  1150cc injections (150cc total volume) 
 
As shown in Figure 46, the key measurements in this study are the flow rates sampled at 
each distal PA branch (LPA and RPA), upper body (SVC), and lower body (IVC) 
circulations. As previously discussed, the pump settings determine the volume injected and 
the volume flow rate per injection. This allows for a complete outlook of the flow field 
properties upon injection: before, during, and after. 
 
Figure 46 Fontan region of interest flow rate Q ̇ sampling schematic. 
 
Two flow field properties have been identified to quantify the jet effect: entrainment and 
jet relaxation time. Given a co-flow configuration with a high-speed jet surrounded by a 
low-speed background flow, entrainment can be defined as the fluid transport across the 
fluid-fluid interface caused by shear-induced turbulence resulting in an increased upstream 




 . . . .
, ,( )ent meas RPA baseline RPA injQ Q Q Q    
(22) 
Where ,meas RPAQ  is the measured flow rate distal of the injection site, ,baseline RPAQ is the 
expected flow to RPA based on known 
.
sQ (systemic flow) and Pas flow split (set to 50-50) 
and ?̇?𝑖𝑛𝑗 in the arranged injection rate. Entrainment results in a positive entQ , whereas 
blockage would entail a negative entQ . Jet relaxation time is defined as the difference 
between jet rise-time and fall-time. Rise-time can be understood as the time-spanning 10% 
to 90% of the flow field response to the injection. Conversely, fall-time is the reverse 
process as the jet winds down. We quantify the jet relaxation time relt  in Equation (23) 
 
rel rise fallt t t   (23) 
Where riset  is the rise-time and fallt  is the fall-time. Positive relt indicates the low likelihood 
of downstream fluid buildup as the co-flow takes longer to plateau than to dissipate the jet 
effect. Negative relt  would suggest a potential fluid buildup. Fluid buildup is an undesirable 
feature in a Fontan circulation model where PVR is assumed constant. Jet relaxation time 
is a particularly powerful quantification in the case of pulsed injection (closely resembling 
actual physiology) as it could highlight a potential fluid buildup that would cascade over 
many cycles. 
 
3.5. Blood Analog 
3.5.1. Newtonian and Non-Newtonian Fluid 
Blood is considered to be a non-Newtonian, where the viscosity is inversely proportional 




in large arteries [225]  The blood carries the non-Newtonian properties at shear rates lower 
than 100 1s .  For in silico and in vitro simulations, the blood is considered to be a 
Newtonian. The non-Newtonian behavior can affect the flow separation and the magnitude 
of WSS. To validate the in-silico experiments using MFL, Newtonian and non-Newtonian 
fluid were developed. For the HCSII and Fontan project, the Newtonian version of blood 
was developed using water and glycerin. The non-Newtonian fluid consists of water, 
glycerin, and nonlinear composition such as surfactant and corn starch compounds. A total 
of thirteen fluids were developed to obtain the analogous version of blood used for in silico 
simulation. The fluids were developed based on varying the percentage composition of 
glycerin, water, and the nonlinear elements. Carreau-Yasuda model was used to develop 
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0 is the zero-shear viscosity,  is the infinite-shear viscosity,  is the shear rate and  
 λ is the relaxation time constant  
The viscosity was measured using The Digital Display Rotary Viscometer NDJ-55, as 
shown in Figure 47. For the viscosity experiment, the rotational viscometer was chosen. 
This viscometer has the advantage of operating continuously at a given shear rate, hence 
preferred during the measurement of absolute viscosity. Viscosity is measured from a 
rotating cylindrical rotor which varies in shape based on the fluid. Torque produced by the 
rotor on the fluid depends on the radius of the rotor. The rotational viscometer identifies 




fluid shear stress is obtained from torque measurements at a given instance, thereby 
determining the viscosity.  The #0 rotor is used for fluids having viscosity values less than 
15 .mPa s ; The rotor comes with a fixed sleeve, a test tube with and without a bottom, and 
a fixed screw for the test tube. The test without the bottom was used to ensure the rotor 
makes contact with the fluid. The test tube ensures that accurate measurements. A smaller 
mirror allows the view of the rotor within the bottomless tube. The mirror ensures if the 
rotor deflects on a specific side. If the rotor deflects, adjustments must be made to move 
the rotor away from the test tube’s inner walls. The rotor should not touch the inner walls 
of the test tube as it would generate skewed results. Further to the centering of the rotor, 
water at room temperature is tested to ensure the viscometer measures accurately as the 
viscosity of water is 1.002 .mPa s at 20 C  
 





Figure 48 Viscosity vs shear rate for non-Newtonian blood model 
Figure 48 represents the plot that corresponds to the viscosity of non-Newtonian fluid vs. 
theoretical value. Viscosity values that are away from the theoretical values due to large 
standard deviations were eliminated. Three out of thirteen fluids developed matched closer 
to the theoretical value having 20%, 40%, and 60 Hematocrit as shown in Figure 49.  The 
fluid with 42% ( 30ml) Glycerin + 44% (30.8ml) water + 13% (9.2ml) nonlinear 
composition followed the viscosity profile that was similar to blood having 60% 
Hematocrit. The fluid with 28.5% (20 ml) Glycerin + 57% (40 ml) water + 14.2% (10 ml) 
nonlinear composition followed the viscosity profile that was similar to blood having 40% 
Hematocrit. The fluid with 45% (18 ml) Glycerin + 52% (20.8 ml) water + 3% (1.2 ml) 






Figure 49 viscosity of non-Newtonian fluid vs theoretical value 
3.6. Oxygenation model 
3.6.1. Oxygenation model for HCSII 
Santamore et al. [226] mentions the lack of natural animal models with HLHS defects. A 
theoretical analysis was performed to determine the blood flow distribution between the 
two circulations in terms of systemic oxygen delivery and its effect. A study was also 
carried out to determine the effect on systemic oxygen delivery and cardiac output due to 





Figure 50 Oxygenation model for HCSII 
In the HCSII model, as shown in Figure 50 shows the right ventricle flow is distributed to 
the upper and lower body circulation. Deoxygenated blood from the upper body flows 
through the SVC to the PAs, and the blood from lower circulation flows through the IVC 
to the right atrium. Flow split between the systemic and pulmonary flow is the primary 
parameter for oxygen content. The oxygen model equations for HCSII are derived from 
the approach carried out by Santamore et al. [226]. This is based on the oxygen uptake in 
the pulmonary circulation, O2 consumption in the systemic circulation, and conservation 
equation. Equation (25) represents the whole body oxygen consumption divided between 
the upper body 
2
. OV and lower body 
2
(1 ) OV  
 
2 2 2





Equation (26) represents the oxygen flow rate into the lower system as a product of lower 
body blood flow IVCQ and arterial blood content 
2
OCa  . The lower body oxygen consumed 
reduces the oxygen flow rate into the lower systemic circulation. The reduced oxygen flow 
rate returns to the right atrium. BIVCO2 represents the oxygen content of the IVC blood.  
 
2 2 2
. (1 ) .O IVC O IVCO IVCCa Q V B Q    
(26) 
Equation (27) represents the oxygen flow rate into the upper body system. The reduced 
oxygen flow rate returns to the PA’s via the SVC  
 
2 2 2
. .O SVC O SVCO SVCCa Q V C Q   
(27) 
Equation (28) represents the PA’s blood flow is equal to the blood flow to the upper 
systemic circulation. Equation (29) represents the total oxygen flow into the pulmonary 
circulation and oxygen uptake into the lungs. This gives the oxygen flow rate that returns 
to the atrium from the pulmonary circulation, 
2
PVOC representing the SVC blood's oxygen 
content. 
  (28) 
 ,
2 2 2
. .LSVCO SVC O PVO PC Q V C Q   
(29) 
Equation (30) represents the relation between the total cardiac output to the upper and 




This is based on the assumption of a steady-state condition. Based on the law of mass 
conservation at the cellular level, oxygen consumption and uptake must be equal 
represented by Equation (31) 
P SVCQ Q
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(31) 
2
.SVCO SVCC Q from Equation (29) is replaced with Equation (27) and PQ replaced by SVCQ




From Equation (30) 
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(34) 


















3.6.2. Oxygenation model for Fontan 
A good source of validation for cardiovascular experiments is to track the projected oxygen 
transport across the model and evaluate the oxygen saturations in systemic and pulmonary 
circulations. 
The Fontan circulation can typically be considered a circuit in series. However, the addition 
of a graft shunting flow from the aortic arch to the Fontan circuit generates a pseudo-
parallel circuit, as shown in Figure 51. The right ventricle (RV) generates a cardiac output 
(CO) which splits in the systemic flow ( sQ ) and the injection jet shunt flow IJSQ . In the 
systemic circuit, oxygen consumption occurs (
2
.
OCV ), which depletes systemic oxygen 
concentration ( 2OCa ) to the systemic venous concentration ( 2SCV OC ) as described in 




equation 1. In the pulmonary circuit, the blood gains oxygen (
.
2S V O ), increasing the 
pulmonary arterial blood concentration ( 2PAOC ) to the pulmonary concentration ( 2PVOC ), 
as modeled in Equation (36).  
 
 











. OPAO p PVO PC Q S V C Q   
(37) 
 
The flow mixing between the systemic venous return and the systemic arterial flow shunted 
by the IJS can be expressed as in Equation (38) 
 
2 22
. .SVO s AO IJS PAO PC Q C Q C Q   (38) 





Based on the circuit schematic, it can be observed that that 
2 2
.PVO P AOC Q C CO  and 
p s IJSCO Q Q Q    which suggests that the systemic oxygen saturation matches the 
pulmonary venous oxygen concentration. The oxygen consumption and assimilation are 
assumed to occur under “steady” conditions hence 
2 2
. .
O OCV S V . Using these observations 
along with the balance equations derived, the systemic oxygen transport equation can be 


























These expressions require cycle-average flow rate inputs originating from experimental 
measurements CO  and   literature-derived blood oxygen capacity and oxygen consumption 
data. Pulmonary venous oxygen concentration is calculated from an assumed oxygen 
saturation (100%, 95%, 90%, 85%, and 80%) depending on patient ventilation and a given 
oxygen capacity 20.22 mLO /mLBlood . Oxygen consumption can be determined based on 
literature derived per-weight oxygen consumption 9  / /mL s kg ; hence the user must only 
know the patient’s weight. 
3.7. Stent and baffle characterization 
Basic stent design involves successions of connectors and rings. Connectors withhold the 
rings, thereby contributing to the longitudinal stability. Rings on the stent provide radial 




connector, and the number of crowns. Based on the size of the vessel, the number of cells 
and crowns change.  
The stent used for the HCSII procedure and the in vitro simulations follow the Palmez stent 
design; the Palmez Genesis Transhepatic Biliary Stent 2510B was used. The stent is 
manufactured by laser-cut operation on a single piece Nitinol tube that follows a closed-
cell design. The need for a weldment is avoided by creating slots during the laser cut 
operation; this manufacturing technique also improves the integrity of the stent. Scanning 
Electron Microscope (SEM) imaging technique captured the characteristic features of the 
stent. Figure 52 A and B represent the average length and width of the strut. Figure 52 C 
and D represent the length and width of the spline feature. Figure 53 E represents the 
distance between the strut and spline feature Figure 53 F represents the outer diameter of 
the spline feature. Figure 52 G represents the diameter of the strut feature. Figure 53 H 
represents the angle of the strut. 
DeCampli et al. specifies the placement of the stent during the HCSII surgical procedure. 
The proposed anastomosis site for RPA and SVC is opened, a longitudinal incision is made 
into the pulmonary trunk to deploy the stent over a 9-2 Opta Pro balloon catheter. A guide 
wire is then advanced incision made on RPA into the left lower lobe artery.  
Table 6 represents the mechanical property of Nitinol material obtained by the annealing 
technique. The mentioned mechanical properties will be used to compute the required 











Figure 53 Palmaz Genesis (PG) 2510B stent characteristic features obtained under SEM 
Table 6 Mechanical properties of Nitinol (annealed) 
Mechanical property Nitinol (annealed) 
Young’s Modulus (E) 
Yield Strength  yp  








Table 7 Geometric parameters of PG 2510B stent 
Geometrical parameter PG 2510B  
Average length of the strut  
Average width of the strut  
Average length of the spline  
Average width of the spline 
Angle between the strut line  
Diameter of the strut feature 
Inner diameter of the spline 
Outer diameter of the spline 
2.445mm 
193.866 µm 







Alfonso et al. [227] mention that mismatches regarding mechanical/functional properties 
between the vascular substitute and native vessel cause a higher failure rate in vascular 
substitute. Commercially available substitutes all low compliance and a reduced dis-
tension capacity in physiological pulsations of the native arteries  
The expanded polytetrafluoroethylene (ePTFE) grafts have different viscoelastic 
characteristics compared to the native vessel.  
 
Figure 54 Gore Preclude Pericardial Membrane 
Gore preclude pericardial membrane made from ePTFE is the baffle material considered 




DeCampli et al. specify the placement of the baffle during the HCSII surgical procedure. 
The baffle material is sutured within the pulmonary bifurcation from the right to the LPA 
orifice. To preserve this exact technique for the in vitro simulation, the baffle is placed 
behind the MPA of the centerpiece. A clamp was designed and 3D printed in order to arrest 
the movement of the baffle. The baffle and the stent complement each other, as the stent 
protects the baffle from being crushed due to the high pressure from the systemic flow.  
3.8. Fatigue Analysis   
High stresses observed in the region of calcified plaque are sufficient to fracture the stent.  
McGarry et al. [228] studied the mechanical performance of stents by modeling stents 
based on the elasticity and isotropic hardening J2 flow theory ( von Mises flow theory). 
Considering the size of the stent strut (< 0.1mm), microscale mechanical properties are 
important. Crystal plasticity theory was used to develop the computational models; the 
theory incorporated both the microscale deformation mechanism and microstructure. 
Models having explicit grain representation is necessary as thin polycrystalline stent has a 
small number of grains across the width. Modeling results showed smooth varying 
localized stress and strain fields using the J2 flow theory compared to the crystal plastic 
theory that predicted non-uniform and localized stress and strain fields. Elementary fatigue 
analysis was performed by the application of pressure pulse to the stent model. Stresses 
generated by the pulse were small compared to stresses during deployment and recoil. 
Fatigue loading is vital for stent and modeling. In the crystal plasticity model, the rough 




Wei et al. [229] studied the structural and hemodynamic analyses to evaluate the 
performance of six different stents. This included Palmaz-Schatz shaped, Xience Prime 
shaped, and Cypher shaped. The other three stents were C-Rlink, C-Rcrown, and C-Astrut. 
Different materials were assigned to the stents, most of them assigned with 316L stainless 
steel. During this study, the Dogboning and recoiling phenomena were observed. 
Dogboning refers to the expansion of the two ends of the stent larger than the center section; 
this has a more significant effect on thrombosis and hyperplasia. Recoiling is defined as 
the “spring back” due to the stent's elastic-plastic deformation. 
Further to simulation, the maximum plastic strain for the six different shapes showed that 
larger plastic strain values meant that the stent could sustain the deformation and results in 
a more significant diameter change. The plastic strain value directly impacted the von 
Mises stress as the change in diameter induced the stress. Combining structural and 
hemodynamic properties, the Palmaz-Genesis stent performed better than the Xience Prime 
and Cypher shaped.  
Stents are prone to fail under various axial, circumstantial, radial loading, and other 
anatomical bending. They also tend to fail due to buckling due to artery wall pressure.  
The displacements in the x and y direction obtained are used to compute the strains in the 
x and y-direction. Since no torque is involved, shear strain and strain in the z-direction are 
excluded. Equations (41) and (42) are used to compute the x strain in the x-direction and 
























Using the stress-strain relation, x , the stress in x-direction and y , the stress in y-
direction are computed using Equations (43) and (44) 
 x xE   (43) 
 y yE   (44) 
The principal stress 1, 2  of the stent is calculated using Equation (45). As the stent material 
is ductile, the liberal failure criterion is used to understand if the stent fails for the given 
loading conditions. Von-misses criterion, using von misses stress, v  along with a factor 
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         
(46) 
High cycle fatigue involves elastically applied stress and a large number of cycles to 
failure. The stress on the component is low, and plastic deformation can occur at any crack 
tip within the elastic region.  Fatigue life is defined as the number of cycles to failure at a 
specified stress value. The number of cycles to failure increases as the applied stress level 
decreases. The number of cycles to failure is also determined by the crack growth rate, i.e., 
the change in the crack length for each cycle. Stress concentrations exist due to the crack 
presence. Figure 55 shows the relation between the cyclic stress intensity factor and the 




value). Once the threshold value is attained, the crack growth is at a rapid phase. Region II 
and III represent the steady-state crack growth and unsteady crack growth.  
 
Figure 55 Relation between cyclic stress intensity and crack growth rate 
The Paris power law is used to compute the number of cycles to failure, Equation (47). 
da
dN
is the crack growth rate, K is the difference of maximum and minimum stress 
intensity factor. C and m are material constants.  In this study, two critical locations were 
considered for the crack to initiate, and based on the critical crack length, the number of 
cycles to failure change 
 mda C K
dN
   
(47) 
The analytical approach to compute the number of cycles to failures involves computing 
the various stresses acting on the stent due to the MPA pressure and baffle. Considering 
the stent to be a cylindrical element, circumferential stress, axial stress, radial stress, and 




established, the stent goes through a uniform loading acting on one side of the 
circumference.  
In this experiment, there exists no axial stress due to the absence of axial loading. The 
method involves computing the hoop stress h   of the stent with the given MPA pressure. 
Equation (48) represents the hoop stress, where p is the pressure acting on the stent, r is 





   
(48) 
Using Von-misses and criterion and Paris law, the number of cycles to failure can be 
predicted. The experimental and analytical study can be validated if the stent will sustain 
the loading condition or fail after the surgical procedure.    
3.9. Otoscope 
The newly formed Intra-pulmonary junction is 18mm in length and 13mm in width on an 
8mm diameter cylindrical surface to measure the normal loading on the baffle surface and 
shear stress due to the fluid flow over the baffle surface. To measure the stress, different 
techniques were analyzed. As stress is a measure of a local variable and it changes based 
on the surface. Hence, strain measurement was considered a global variable, from strain 
compound stress acting on the baffle, can be identified. Due to the complexity of the 
patient-specific geometry, various measuring techniques were analyzed. Also, the 
experiment will be running for 12 days continuously. Hence waterproof and sensor 
reliability are considered.  
Some of the techniques considered during the literature survey are Force (Piezoelectric) 




based sensors, Non-intrusive optical measurement techniques, and intrusive optical 
measurement techniques.  
Many sensors were ruled out because of the very small dimension and the need for 
flexibility in the sensing element. Force sensors are not considered because of the 
measurement of stress instead of strain. Strain gauges and pressure couldn’t be used as it 
excited when to bend to our desired shape. MEMS were considered for best options for 
this case, but no such off-the-shelf sensors are available; they need to be fabricated as a 
custom product. The fabrication time usually takes a minimum of 6-8 months with testing 
and verification, so these sensors were not used. As the entire geometry is complex in 
shape, rapid prototyping was considered an option for developing a centerpiece. As the 
region of interest is below the pulmonary artery, a direct view of the baffle is obstructed 
even when printed using a transparent material. In the end, intrusive optical measurements 
were considered.  
Design limitation in selecting intrusive cameras is that the diameter of the probe should be 
less than 5mm as the total diameter of the pulmonary arteries is 8mm. The cut section of 
the pulmonary artery allows the opening of 5.2mm to view the baffle. The camera probe 
should not block the flow passing through the pulmonary artery. Hence endoscopic camera 
and borescopes were considered as an option to get the video of the deformation of baffle—
another limitation in the fluid that passes through the pulmonary artery. The camera should 
be able to view the distal end of the pulmonary artery when fluid is passing. The borescope 
camera lacks clarity, and fixed focus also lacks magnification. In the end, Firefly, Digital 
Video Otoscope, as shown in Figure 56 A. Otoscope angle and ditance B. Slot for otoscope 




due to its magnification ability similar to the microscope and varying focus but came with 
a drawback as it’s not waterproof. Hence camera should place away from the surface by 
keeping a transparent material. The specula provided with the camera is 3 and 4 mm in 
diameter, which suits our requirement. 
The Firefly Digital Video Otoscope became the preferred device to capture the stent and 
baffle movement. For a wider field of area, the 4mm probe is selected. The Digital otoscope 
has a proper 1.3 Megapixel resolution and a variable magnification up to 150X (digitally) 
and up to 50X (Optically). Video is captured at a rate of 30 fps. The software comes with 
a measuring tool and recording tool for easy post-processing of the images for dimensions. 
Placing the camera at an angle and capturing the whole stent was the constrain as 
components blocked the lens in the centerpiece. Hand calculations show that the camera 
should be placed 19.263mm from the proximal end of the stent and 4.84mm in depth at an 
angle of 24.333⁰. The values are computed based on the CAD design discussed in section 
3.1.1.3. The specula are not interfering with any components of the centerpiece and can 





Figure 56 A. Otoscope angle and ditance B. Slot for otoscope C. Side view of Otoscope and stent 
D. The Firefly Digital Video Otoscope 
 
3.10. Uncertainty  
Uncertainty quantification is the process in which the uncertainties are characterized 
quantitatively and reduced in an application. Their likelihood of specific outcomes is 
determined if some aspects of the system are not known. Uncertainty existence is possible 
in a mathematical and experimental model, which can be categorized into various sources 
such as parameter, structural, exponential, interpolation,  aleatoric and epistemic.  
Experiments mentioned in this report use the sensors to obtain the required output. 
Uncertainty of sensors can be classified into three types, point, interval, and probabilistic.  
3.10.1. Type B Estimates 
Type B Estimate is used when the statistics of error distribution is done by knowledge of 




display resolution, operator bias, along with computational and environmental factors, are 
determined using this technique.  
Normal Distribution  















 L is defined as the containment limit, 1  the inverse normal distribution function, and 
the containment probability [230] Generally, the containment limits are obtained from 
manufacturer tolerance limits, calibration records, or statistical process control limits. The 
containment probability is derived from service data from the past. This study aimed to 
understand the effect of system-level uncertainty on pressure and flow readings obtained 
during in-vitro simulations  
For the pressure sensors, errors associated with accuracy that combines errors due to 
linearity, hysteresis, and repeatability are considered. Other errors that are considered 
include setting zero offset and span error, the total error band that includes errors due to 
thermal hysteresis, and thermal errors.  
Upon establishing the type of error, the corresponding error limits are defined as a number 
or as a percent of the full-scale reading. The error limits are to be defined by the confidence 
interval or by a specified level of probability. All the error sources associated with each 
individual system are assumed to follow a normal distribution. For calculation purposes, 




Based on the equation, the uncertainty due to each error is computed based on the error 
limit. This leads to the development of the standardized error model along with the 
sensitivity coefficients. The model is further simplified as no correlation exists between the 
individual error sources. The degree of freedom and confidence limit are considered for 
the final uncertainty.  
3.11. Statistical Analysis 
3.11.1. Hypothesis 
Hypothesis testing is defined as the procedure that involves making decisions based on 
the nature of the distribution (nonparametric) or the parameter's value (parametric). 
Standard parametric hypothesis tests involve the z test and t-test. Nonparametric 
hypothesis tests involve median test and KS test.  
3.11.2. Statistical testing  
The null and the alternate hypothesis are formulated along with the significance level (α). 
The test statistic Y(X) = Y(X1,X2,X3….Xn) is constructed, and its distribution has to fall 
under H0. A critical region U is defined for the test statistic Y. The critical region 
determines whether H0 is rejected if Y falls inside the region, such that   
0( ( ) )HP Y X U    
PH0 indicates the inequality is true for all parameters of the population which belong to H0. 
The value of the critical region is given by Y(X), and the value does not fall under the null 
hypothesis. y(x) = Y(x1,x2,x3….xn) is computed based on the sample data X1= x1, X2= x2. 




The null hypothesis is not rejected when y(x) falls outside the critical region. A test is 
considered statistically significant if and only when the H0 is rejected.  
3.11.3. p-value 
The p-value is often used in replacement for the critical region to accept or reject the null 
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(50) 
For the null hypothesis to be rejected, the p-value should be smaller than the significance 
level α. The p-value is a random variable, and it follows a normal distribution under the 
null hypothesis.  
3.11.4. Z-test  
Another way of performing a hypothetical test is using the z-test, where the statistic follows 
a normal distribution curve. The normal distribution is mostly used in real-life scenarios. 
The central limit theorem states that if the sample size is at least 30 and the sample size 
remains the same, the distribution of the sample mean is approximated by a normal 
distribution. A variable X follows a normal distribution if the probability density function 
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(51) 
The above equation is usually represented as X ~ N(µ,σ2) and the parameters of the 




a normal distribution with parameters mean, µ =0 and standard deviation  =1 denoted by 
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(52) 
The test statistic for the z test is represented as Equation (53), where x  is the observed 








The value obtained is compared against the p-value, and the corresponding step involves 
the acceptance or rejection of the null hypothesis. 
Experiments associated with HCSII, and Fontan are conducted with different objectives. 
Such experiments are conducted multiple times that represent ‘n’ number of heart cycles 
having the same hemodynamics characters to that of the patient who recently underwent 
the clinical procedure. 
The hypothesis testing for HCSII involves a comparison of in-vitro results obtained with 
in-vivo results. This comparison is done by conducting a z-score. The null hypothesis for 
this testing is the studies performed are indifferent with respect to the hemodynamics 






4.1. Experimental Set-Up  
As discussed in section 3.2, both MFL setups discussed in this study are based on a reduced 
LPM. Each R, L, C parameter in the LPM has a specified value derived from clinical 
measurements. The values for these parameters are physically realized in both MFL setups 
through respective replicating components as explained in 3.2.1 and 3.2.2.  The key to 
achieving meaningful results in MFL setups highly depends on the accurate tuning of these 
individual components and data acquisition. Great precision is maintained during the 
tuning process. Imprecision of one component can lead to an incorrect response of the 
whole system. As discussed in section 2.2, there are various methods by which MFL setups 
can be devised for conducting different kinds of experiments. In this study, each MFL is 
specifically designed to investigate the hemodynamics of the two proposed surgical 
procedures. Though both MFL setups have been developed to achieve distinctly different 
research objectives, both MFL setups share the same principal tuning approach.  
Both the MFL setups are systematically tuned by following a bottom-up procedure that 
involves the sequential execution of the following steps:  
I. Set the correct Atrium pressure  
II. Tune the Harvard Apparatus pulsatile blood pump to produce the required CO 
III. Turn ON the NI DAQ 9361, NI 9205, and open the developed LabVIEW project 
code to start data acquisition 
IV. Tune the systemic and pulmonary resistances to achieve the flow splits by shutting 




V. After attaining the correct flow splits in every compartment, then open compliance 
chambers to attain the correct pressure waveforms in every compartment of the 
MFL 
VI. Log the hemodynamic data from the flowmeters and pressure sensors using the 
LabVIEW code.  
VII. Import the unfiltered logged data using the Matlab post-processing scheme to 
compute the final filtered results.  
In the following subsection, experimentation of both HCSII and Fontan procedure is 
explained in detail.  
4.1.1. Experimentation of HCSII  
The experimentation of HCSII was conducted for two patient subsets with different CO. 
As mentioned in 3.2.1, the MFL setup majorly consists of four compartments, i.e., Upper 
systemic, lower systemic, left pulmonary, and right pulmonary circulations. The 3-D 
printed phantom replicating the reconstructed HCSII physiology, described in 3.1.1.4, has 
been integrated with the physical components replicating the R, L, and C parameters of 
the reduced LPM. Figure 57 shows the complete MFL setup of the HCSII circulation. 
This research study's prime focus is to investigate the hemodynamics of the proposed 
HCSII circulation; hence, VSD and the Glenn procedure are modeled in the LPM as a 
peripheral component to this simulated surgical procedure. Hence to physically represent 
the VSD  feature in the MFL, two resistor valves are used, and the Glenn procedure is 






Figure 57 MFL set up of HCSII circulation  
Figure 58 shows the location of resistors, flow, and pressure sensors in all four 
compartments of the MFL. After the Harvard apparatus pump is tuned to produce the 
required CO, these upper and lower systemic resistors need to be tuned such that the flow 
split between the upper and lower systemic is maintained. Also, the pulmonary resistances 




 ratio is maintained.  
Figure 59 shows the integration of the sensors and the resistors to the 3-D phantom in the 
MFL. Pressure and flowrate in the MPA, ascending, and descending aorta are maintained 
by tuning those respective resistances. Pressure from the MPA section over the baffle, 





Figure 58 Position of devices in the MFL setup  
 
 




Figure 60 shows all the four compartments of the MFL. Once the correct flow splits are 
achieved by tuning these resistances, then all the compliance chambers are re-engaged. In 




Figure 60 Systemic and Pulmonary circulation in the MFL 
To conduct an in-situ PRT experiment a high-speed SONY DSC-RX10 III cybershot 
camera is installed in the MFL by calculating the hyperfocal distance between the camera 
lens and the MPA conduit present in the 3-D phantom as shown in Figure 61. Two non 





Figure 61 In-situ Image acquisition in the MFL setup  
Figure 62 shows the front panel of the LabVIEW code that has been developed to acquire 
the hemodynamic data from the MFL. All the integrated digital and analog sensors in the 
MFL are connected to NI DAQ 9205 (analog module) and NI DAQ 9361 (digital 
module).  All live transient and cycle averaged hemodynamic waveforms acquired from 





Figure 62 Developed data acquisition and User interface  
While acquiring the data during experimentation, noise interference is observed. The 
trend of noise interference has been consistent for both experimental runs (patient-1 and 
patient-2). A low-pass Chebyshev type-2 filter is designed to filter the noise. The filter 





Figure 63 Magnitude and Phase response of  filter A. Patient 1 B. Patient 2 
 




Hence after conducting an FFT spectral analysis of the waveform obtained for both 
patient subsets, a proper cutoff frequency is selected. The spectral analyses of pressure 
and flowrate waveforms for both patients can be seen in Figure 65-Figure 68.  
 
 







Figure 66 FFT of flowrate waveform for Patient 2 
 
 






Figure 68 FFT of pressure waveform for Patient 2 
Finally, after implementing the chebyshev type-2 filter, another digital filter called 
savitzky- Golay filter is applied to smoothen out the waveforms. To keep the brevity, the 
effect of this combined filtering algorithm is shown in Figure 69 for the pressure 





Figure 69 Orginal and filtered Pressure waveforms of Patient 2 
4.1.1.1. In-Situ Stent Deformation 
As explained previously in 3.9, an in-situ stented baffle tracking in the PA conduit is one 
of the key aims of this study. The stented baffle displacement is occurring due to the 
pulsatile loading of the MPA conduit. Stented baffle tracking is done by developing an 
in-house computer vision code. This code is developed based on the Lucas Kanade 
Tracker algorithm. While conducting the MFL experimentation, videos of the stented 
baffle displacement are acquired by using the otoscope. These videos are acquired under 
varying lighting conditions and focus. After importing the videos using the computer 
vision code, a bounding box is created on the region of interest. The tracker algorithm is 
used to track the Eigen features of the stent during each cardiac cycle as shown in Figure 
70. Finally, each tracked location is post-processed and the displacement of each tracker 





Figure 70 Stent and baffle tracking 
4.1.1.2. Particle Residence Time 
The particle residence time (PRT) analysis explains the probability of thrombus 
formation and pathological flows in this reconstructed physiology. To achieve this goal, 
particles of 2mm diameter in size are injected into the flow stream of MPA. The injected 
particles closely matched the density of the blood analog that is acting as the working 





Figure 71 PRT: A: Early systole, B: Peak systole, C: Early Diastole, D: Late Diastole 
To track the pathlines of the injected particles, a multi-object Kalman tracker is developed. 
The main goal of the tracker is to successfully track all the particles once they enter the 
MPA conduit till those exits out through the DA conduit. The high-resolution video of 
particle motion was captured with 1000 FPS using the camera. Video has been 
preprocessed by running a stabilizing scheme to control the blurring and video vibration. 




properties are tuned for detecting the particles during systole and diastole as shown in 
Figure 72 
 
Figure 72 Particle tracking study using Kalman tracker during systole and diastole a original 
video b. preprocessing c. Kalman tracker 
4.1.2. Experimentation of Fontan  
The Fontan circulation is modeled in a way the upper systemic circulation receives 
approximately 30% of the total systemic blood flow while the lower systemic circulation 
receives approximately 70% of the total systemic blood flow. In the pulmonary circulation, 




Thus, the vascular resistances are initially adjusted or tuned to control the ratio of flow 
within two parallel lumps of the flow loop. Once the flow ratios had been met, the 
compliance chambers are engaged while maintaining the appropriate flow ratios. Then, IJS 
graft line is turned on by incorporating the correct IJS graft as mentioned in 3.1.2. In this 
experiment, various sizes of the IJS nozzle and different angles of anastomosis, and the 
effect of PVR are simulated, as shown in Figure 73 and Figure 74.  
 






Figure 74 Mock Flow Loop set up with DAQ and compliance chambers 
 





There is a significant amount of noise interference in the flow and pressure field during 
experimentation once various parameters are tested out. A butterworth filter and the 
savitzky-Golay filter are applied to the final post-processed data to filter out these noises. 
To maintain the brevity in this section, only the performance of the most qualified cases 
from each of the three parameters (nozzle size, anastomosis angle, PVR %) are discussed 
here. The filters are applied to the flowrate waveforms for each lump and IVC pressure. 
Figure 76-Figure 83 shows the filter characteristics for each of the most qualified cases. 
Pole-zero plots of all these filters show that the designed filter is very stable in 
performance. Each filter's magnitude and phase response describes a smooth transition 
from the passband to stopband frequency.  
 





Figure 77 Magnitude and phase response of flowrate at A. Upper B. Lower C. Left D. Right for 3 
mm IJS at 5 degree 
 






Figure 79 Magnitude and phase response of flowrate at A. Upper B. Lower C. Left D. PVR 30 
 







Figure 81 A. Magnitude and phase response B. Pole-Zero plot of IVC pressure for 3mm IJS   
 







Figure 83 A. Magnitude and phase response B. Pole-Zero plot of IVC pressure for PVR 30 
The spectral analysis on all flowrate waveforms for all three parametric studies has been 
performed to understand the noise interference pattern, as shown in  Figure 84 - Figure 
86. Depending on the peak frequency, a cutoff frequency has been selected and applied to 
develop the filters.  
 





Figure 85 flowrate FFT of 3mm IJS at 5 degree 
 
Figure 86 flowrate FFT PVR30 
Figure 87- Figure 89 show the unfiltered flowrate waveforms for the qualified cases of 






Figure 87 Unfiltered flowrate for 3mm IJS 
 






Figure 89 Unfiltered flowrate for PVR30 
Figure 90 to Figure 92 show the comparison of the filtered and unfiltered flowrate 
waveforms after implement this filtering scheme. By comparing the systolic and diastolic 
features between filtered and unfiltered waves, it can be seen  that embedded noise is 







Figure 90 Filtered and Unfiltered flowrate for 3mm IJS 
 
 






Figure 92 Filtered and unfiltered flowrate for PVR30 
In the same fashion, the filtering scheme has been applied to the analog pressure sensors. 
To successfully implement the filtering scheme, spectral analyses have been performed 
on each of the pressure sensors present in each compartment of the MFL, as shown in 





Figure 93 Pressure FFT 3mm IJS 
 
 






Figure 95 Pressure FFT PVR30 
 
Figure 96 to Figure 98 show the unfiltered pressure waveforms for all the best cases of 





Figure 96 Unfiltered Pressure for 3mm IJS 
 






Figure 98 Unfiltered Pressure for PVR30 
Figure 99 to Figure 101 compares the filtered and unfiltered pressure waveforms after 
implementing this filtering scheme. By comparing the systolic and diastolic features 
between filtered and unfiltered waves, it can be seen that embedded noise is filtered out.   
 





Figure 100 Filtered and unfiltered pressure for 3mm IJS at 5 degree 
 
 








4.1.3. PVR and entrainment study  
 
Figure 102 MFL setup for PVR study 
Figure 46 represents the TCPC used for this experiment. The catheter is represented by 
the conduit placed on the RPA side. The site of the injection site is shown in Figure 102. 
A 7Fr catheter (outer diameter 2.3368 mm) was used with the injection pump during the 
experiment. The injection pump is user-controlled equipment that was used during the 
experiment. The controls on the pump allow the user to vary the flow rate, and the 
volume to inject during each burst. The pump is programmed manually prior to a given 




right pulmonary and left pulmonary circulation. The loop is tuned by setting the Harvard 
pulsatile pump to 80 bpmand 30 /cc s as the stroke volume, thereby replicating a cardiac 
output of 2.4 
min
L . A single cardiac beat represents 30% systolic and 70% diastolic. 
Resistors were tuned to achieve the required flow splits in the conduits. The upper 
circulation is having 30% flow and 70% flow towards the lower circulation. At the 
Fontan TCPC, the flow is equally split between the LPA and RPA. The baseline attained 
is of normal Fontan. The MFL operated with the baseline condition for one minute. After 
60-70 seconds, the injections were pushed. Each protocol developed by the 
interventionist was conducted 3 times.      
4.2. Experimental Results  
4.2.1. HCSII 
In this section, first, the hemodynamic quantifications are discussed and then followed by 
quantitative and qualitative analyses of other parameters like stented-baffle displacements 
and particle residence time are presented.   
4.2.1.1. Hemodynamic 
As mentioned in the previous section 4.1.1, experimental runs are made to match the 
catheter reports of two patients. Table 8 and Table 9quantifies and compares the 
hemodynamics of both patients obtained by experimental runs and the catheter reports 
provided by our clinical partners.  This table shows that results obtained by in-vitro 
experiments closely match with the in-vivo results. Results show that flow splits in the 
systemic and pulmonary circulations fall under the clinically acceptable range in the 




the upper systemic, lower systemic, left pulmonary, and right pulmonary circulations, 
respectively.   
Table 8 Hemodynamic flowrate results obtained using Catheter data and MFL for patients 1 and 2  
 P1 P2 
 Catheter data MFL Catheter data MFL 
[ ]
minupper
LQ  1.25 1.288 0.76 1.079 
[ ]
minlower
LQ  1.74 1.865 0.99 0.747 
[ ]
minLPA
LQ  0.50 0.646 0.31 0.527 
[ ]
minRPA
LQ  0.75 0.642 0.45 0.552 
[ ]
min
LCO  2.99 3.153 1.75 1.826 
 
Table 9 Hemodynamic pressure results obtained using Catheter data and MFL for patient 1 and 2 
 P1 P2 
 Catheter data MFL Catheter data MFL 























  rpaP mmHg  8 10.835 11 12.726 
 
In Table 9, the Pmpa, Pu, Pao, Pda Plpa  Prpa represent pressure measured in MPA conduit, 
Upper systemic, ascending aorta, descending aorta, left pulmonary artery, and right 
pulmonary artery, respectively.  
Our clinical collaborators provided the following catheter waveforms for two deidentified 
patients, as shown in Figure 103 to Figure 105.  
 





Figure 104 Pressure plots obtained from catheter data for patient 1 
 
 
Figure 105 Pressure plots obtained from catheter data for patient 2 
Flowrate: 
Figure 106 and Figure 107 depict the features of the filtered flowrate waveforms obtained 





Figure 106 Filtered flowrate of patient 1 
 





These are the pressure waveforms as shown in Figure 108, and Figure 109 are obtained 
from the MFL experimental runs. These waveforms closely match with features of the 
catheter waveforms.   
 
Figure 108 Filtered pressure of patient 1 
 





4.2.1.2. Statistical analysis (z score) 
The hemodynamic parameters obtained after conducting the experiment are compared 
against the catheter data. The null hypothesis for this testing states no difference in the 
hemodynamic parameters between the surgical and experimental procedures. The alternate 
hypothesis states that there is a difference in the parameter’s values. The two tail z-score 
test was performed at a significance level of 0.1. The p-value for this test was 0.784. The 
p-value obtained during testing is greater than the significance level 0.1, thereby rejecting 
the alternating hypothesis and accepting the null hypothesis.   
 
4.2.1.3. Oxygen  transport  
Oxygen transport is reported for both patient subsets. The oxygen delivery and saturation 
are reported with different pulmonary vein saturations values (100%, 95%, 90%, 85%) as 






Figure 110 Systemic Oxygen saturation level between patient 1 and patient 2 
In-vitro oxygen transport analyses for patient 1 closely matches with the in-silico findings 
conducted by Hameed et al. [224].   
4.2.1.4. Stented-Baffle tracking 
The tracking algorithm has successfully tracked the displacement of the stented baffle 
geometry under the pulsatile loading condition for eight cases, as shown in Figure 111. 
The marked minimum displacement 0.17 mm and maximum displacement  1.88 mm. The 
average displacement is 0.65 mm. It is also observed from Table 10 that stented- baffle 
displacement is a function of CO. As the CO decreases the stented- baffle displacement 












Table 10 Displacement of stent at various sites for patient 1 and patient 2 





























4.2.1.5. Fatigue Study 
The crushing of the baffle is due to the stress from the outside system flow. The pressure 
value of MPA is obtained for each heart cycle, and the pressure acts on the baffle, thereby 
causing the stent to displace from its original location. For each pulsatile loading, the stent 
is being displaced. The following paragraphs explain the numerical computation carried 
out to obtain the stress acting on the stent.  
As the stent is placed horizontally and parallelly to the PA conduits, the pressure between 
the LPA and RPA sides is used to compute the hoop stress acting on the cylinder. The 
maximum hoop stress is computed, and the minimum hoop stress is zero. For the given 
loading condition, the principal stress is computed and compared with von-misses stress 





Patient 1 had an average LPA-RPA pressure of 12.840234 mmHg that corresponds to 






0.067 MPahoop   
As the stent does not have any loading in other directions and there is no torsion loading, 
x and xy  is equated to zero. Therefore, there exists one principal stress. For the given 
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The above value represents the 1 , i.e., the principal stress acting normal to the plane in 
which the shear stress is zero. The first principal stress is the maximum value seen on the 
stent material during the loading conditions. Von-mises stress criterion with Factor of 
Safety 2 identifies if the stent will be crushed due to the pulsatile loading during a given 
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From the above equations, it can be established that the maximum stress acting on the stent 
and minimum stress is zero. The stent reaches the maximum and minimum stresses in a 
repetitive pattern (cyclic). The cyclic pattern occurring for ‘N’cycles makes the stent 
undergo a fatigue failure at the Nth cycle. The principal stress obtained above provides an 
insight that the stent will undergo high cycle fatigue failure as the stress applied falls well 
within the elastic region.  
For calculation purposes, critical crack length was identified at two specific locations, as 
shown in Figure 112. Figure 112A represents location one, and Figure 112 B represents 
location two to compute the number of cycles to failure if a crack occurs at the crack tip., 
The exact number of cycles to failure can be computed by knowing the change in the crack 





Figure 112 Critical locations for crack propagation 
For calculation purposes, few assumptions are taken into consideration. The initial 
critical crack length is assumed to be zero, and a steady crack growth rate is assumed at 
the location of failure. The Paris law equation is used to provide the number of cycles to 
failure. The Paris law is based on the material properties and loading conditions. The 
equation is integrated using two different limits; the crack length is integrated from initial 
to final crack length, the number of cycles is integrated from zero to final. The modified 
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(54) 
Where fN  is a number of cycles to failure, ca is critical crack growth, ia initial crack 











































Patient 2 had an average LPA-RPA pressure of 13.8015035 mmHg that corresponds to 
1840.05 Pa  
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The above value represents the 1 , i.e., the principal stress acting normal to the plane in 
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From the above equations, it can be established that the maximum stress acting on the 
stent is lower than the yield stress of Nitinol. Using the Paris law given by Equation 51 to 
compute the number of cycles to failure at two different locations with two different 
critical crack lengths. 









































The number of cycles to failure is computed for the critical locations and compared based 
on the LPA-RPA pressure values. It is seen that the stent goes through high cycle fatigue 
failure for the giving loading conditions. Table 11 provides the summary for the fatigue 
study conducted based on patient one and patient two data.  
Table 11 Conclusion summary of fatigue study on the stent for patient 1and patient 2 data  
Type of study  Location Number of cycles to failure  
Circumferential Stress (patient 1) 
 






129.10  cycles  
121.13.10  cycles  
11 7.15.10 cycles  
121.42.10  cycles  
 
4.2.1.6. Particle Residence Time  
Particle residence time is the amount of time taken by a particle in the flow stream to exit 
an outlet boundary. PRT study indicates any pathological flow present in the domain and 
the risk of thrombus formation. In Figure 113, the Kalman tracker has successfully 
tracked all the particles injected in the flow field. The particles have been tracked in the 










Figure 114 Particle path lines (left) Particle velocity (right)  
After analyzing all the path lines generated from each tracked particle, as shown in 
Figure 114, the result showed that, on average, each particle exited the MPA conduit 
within 2.8 s to 3.2 s. This result proves that this reconstructed physiology does not have 
any pathological flow or any probability of flow recirculation.  
4.2.2. Fontan with IJS 
4.2.2.1. Comparative study of IJS nozzles: 2mm, 3mm, and 4mm 
The purpose of this study is to determine whether the implementation of an IJS would 
prove beneficial for Fontan patients. To this goal, the MFL is first tuned to match the 
physiological conditions of a failing Fontan with elevated caval pressure around 20 mmHg  
and a systemic flow of  2.03 
min
L . Following tuning, the study assesses the IJS viability 
by altering two parameters. First, the IJS is sequentially activated to mimic various 
proximal aortic anastomosis angles, and then the PVR is reduced, as shown in Figure 115. 
Table 12-Table 14 provides an overview of the flow and pressure measurements obtained 
by conducting the parametric study on IJS nozzle diameter, change in anastomosis angle, 





Figure 115 IJS proximal anastomosis angle. 
As it can be seen from Table 12, the 3mm IJS nozzle has proved to be the best candidate 
in the parametric study on IJS nozzle size. By using the 3mm IJS nozzle, a caval pressure 





Hemodynamic pressure and flowrate waveforms for all the cases of nozzle study are shown 
in Figure 116 to Figure 121. First, all the flowrate waveforms generate from all three nozzle 
sizes are discussed and then, followed by all the pressure waveforms are discussed. 




 No-IJS 2mm  3mm  4mm  
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Figure 117 Filtered flowrate 3mm IJS 
 
 








Figure 119 Filtered pressure 2mm IJS 
 
 






Figure 121 Filtered pressure 4mm IJS 
4.2.2.2. Comparative study of angles : 5,45 and 90 degree 
In  Table 13 the implementation of the IJS clearly results in a significant pressure drop in 
IVC. Upon tuning the measured IVC pressure is of 20.75 mmHg  with a systemic flow of 
1.51 
min
L , following the IJS implementation at a 90angle the pressure drops to 17.58 
mmHg  and the systemic flow is 1.03 
min
L . At an 45angle the pressure further drops 
to 16.38 mmHg  and at 0  angle the pressure is found to be 16.20 mmHg . Once the IJS 
is activated the sQ remains mostly constant however the IVC pressure sees up to a 1.38 
mmHg drop. This notable pressure drop is due to the kind of pressure the proximal IJS 
takeoff is subjected to. In the 90case the flow across the IJS is driven solely by the static 
pressure in the aortic arch. On the other hand, in the 0case the IJS flow is powered by the 








 constraint is met at about 1.65. Hemodynamic pressure 
and flowrate waveforms for all the cases of IJS anastomosis angles are shown in Figure 
122 to Figure 127.  This study does not include a feedback mechanism to maintain 
homeostatic systemic flow. This results in the observed drop in sQ following the IJS 
activation. 
Table 13 Pressure and flow measurement for active 3mm IJS with varying angle  
  
 
Active 3mm IJS 
















[ ]IVCP mmHg  
 






































In  Table 13 it can be observed that pQ  increases following IJS activation from the baseline 
value of 1.53 
min
L  to 1.69 
min






Figure 122 Filtered flowrate of 3mm IJS at 5 degree 
 





Figure 124 Filtered flowrate of 3mm IJS at 90 degree 
Pressure:  
 





Figure 126 Filtered pressure of 3mm IJS at 45 degree 
 
Figure 127 Filtered pressure of 3mm IJS at 90 degree 
 





Per our hypothesis, as flow to the pulmonary system increases PVR drops. Table 14 
summarizes results for varying PVR. As PVR decreases there is not a significant change is 
either sQ  or pQ . IVC pressure however is significantly affected. Staring from the most 
optimal IJS implementation angle of 0 the PVR is first dropped by 10%  resulting in a 
14.41 mmHg IVC pressure. A further PVR drop to 20% of baseline decrease IVC pressure 





Hemodynamic pressure and flowrate waveforms for all the cases of IJS anastomosis angles 
are shown in Figure 128. Figure 131.  
Table 14 Pressure and flow measurements for active IJS and decreasing PVR 
 Active 3mm IJS 0°  

















[ ]IVCP mmHg  
 




















Before dropping PVR, the IVC pressure drop totals at 4.55 mmHg . Once PVR is reduced, 




implementation of an IJS alone can be very beneficial to a Fontan patient. The further 









Figure 129  Filtered flowrate PVR30 
Pressure 
 





Figure 131 Filtered Pressure PVR30 
 
4.2.2.4. Oxygen transport  
Following the tabulated Table 13 and Table 14 flow measurements presented in the earlier 
section, the oxygen transport in the systemic arterial and venous sides can be evaluated. 
Due to the lower 𝐶𝑂 used in these experiments, the oxygen consumption rate per unit 
weight had to adjust accordingly. As described in the literature, the oxygen consumption 
rate can have a linear relationship to the cardiac out, hence based on these results  the 
consumption rate was linearly scaled down to 6.3 /mL s
kg
. The results that follow present 
oxygen saturations for the systemic arterial and venous circuits for different pulmonary 
venous saturation (representing various degrees of oxygen extraction by the lungs) for each 
Fontan model explored offers a complete overview of the oxygen saturation calculations. 
It can be readily observed that, as mentioned in the oxygen model description, the systemic 




saturation. The arterial saturations calculated fall within the acceptable range. Due to the 
oxygen transport model employed, the systemic venous saturations are highly dependent 
upon the correct implementation of the consumption rates. As mentioned earlier, the 
consumption rate found in the literature was scaled down accordingly to match the CO 
used in these experiments. The resulting systemic venous saturation falls within the 
expected range, particularly for the baseline case, which can be readily compared to clinical 
data. This indicates that the consumption rate scaling was performed correctly. Baseline 
and models implementing the IJS only differ for systemic venous saturations. This 
difference is due entirely to the strong drop-in sQ  that occurs when the IJS valve is opened. 
Once the IJS becomes active, proximal shunt anastomosis angle and PVR reduction do not 
strongly affect oxygen saturation. In general as the pulmonary venous saturation drops the 
systemic arterial and venous saturation follow the same trend. 
Figure 132 takes a closer look at the arterial and venous saturation separately. The 
decreasing trend in oxygen saturation with dropping ventilation is clear. The strong drop 




of noticeable change in saturations (especially on the venous side) due to model alterations 
(IJS takeoff angle and PVR). 
 
Figure 132 - Systemic arterial (A) and venous (B) oxygen saturations for various pulmonary 
venous saturations (SpvO2) in all the models explored. 
The results presented in this section offer a good degree of validation for the oxygen 
transport model implemented. The computed quantities match expected trends and can be 
readily compared to clinical data. 
4.2.3. PVR entrainment Study 
4.2.3.1. Hemodynamics for PVR protocol 
As per the described protocol in section 3.3, experimental runs for all short and long bursts 
of injections in the LPA conduit are conducted. The pressure levels in all four sections are 

















Systemic Arterial O2 Saturations across MFL loop















Systemic Venous O2 Saturations across MFL loop






value of each protocol that was conducted for three times. From Table 15 to Table 22, it 
can be concluded that there is no appreciable change to the pressure in the PAs. In this 
result section, Figure 133 to Figure 148 plots the hemodynamic response of the MFL for 
all significant type of short and long bursts of injections.   
Flow rate and pressure waveforms are captured during the experiment. Peaks of pressure 
waveform tend to be consistent during the experimentation, proving that the injection 
protocol does not increase the pressure at the injection site during in-vitro studies.   
 
Table 15 Short multiple injections at 5cc/s A. Flowrate values B. Pressure values 
A 
5cc/s 
Flow rates ( / )L min  





5 x 20cc 
(100cc) 
5 x 15cc 
(75cc) 
10 x 10cc 
(100cc) 








































Pressure  mmHg  




5 x 20cc 
(100cc) 
5 x 15cc 
(75cc) 
10 x 10cc 
(100cc) 












































Figure 134 Filtered pressure for 5cc/s with 20cc volume for five shots 
 
Table 16 Short multiple injection at 10cc/s A. Flowrate values B. Pressure values 
A 
10cc/s 
Flow rates ( / )L min  





5 x 20cc 
(100cc) 
5 x 15cc 
(75cc) 
10 x 10cc 
(100cc) 















































Pressure  mmHg  
upperP  lowerP  RPAP  LPAP  aorticP  
5 x 20cc 
(100cc) 
5 x 15cc 
(75cc) 
10 x 10cc 
(100cc) 













































Figure 136 Filtered pressure for 10cc/s with 20cc volume for ten shots 
 
Table 17 Short multiple injection at 15cc/s A. Flowrate values B. Pressure values 
A 
15cc/s 
Flow rates ( / )L min  





5 x 20cc 
(100cc) 
5 x 15cc 
(75cc) 
10 x 10cc 
(100cc) 















































Pressure  mmHg  
upperP  lowerP  RPAP  LPAP  aorticP  
5 x 20cc 
(100cc) 
5 x 15cc 
(75cc) 
10 x 10cc 
(100cc) 














































Figure 138 Filtered pressure for 15cc/s with 20cc volume for five shots 
 
Table 18 Short multiple injection at 20cc/s A. Flowrate values B. Pressure values 
A 
20cc/s 
Flow rates ( / )L min  





5 x 20cc 
(100cc) 
5 x 15cc 
(75cc) 
10 x 10cc 
(100cc) 















































Pressure  mmHg  
upperP  lowerP  RPAP  LPAP  aorticP  
5 x 20cc 
(100cc) 
5 x 15cc 
(75cc) 
10 x 10cc 
(100cc) 












































Figure 140 Filtered pressure for 20cc/s with 20cc volume for five shots 
Table 19: Long single injection at 5cc/s A. Flowrate values B. Pressure values 
A 
5cc/s 
Flow rates ( / )L min  





1 x 50cc 
(50cc) 
1 x 100cc 
(100cc) 








































Pressure  mmHg  
upperP  lowerP  RPAP  LPAP  aorticP  
1 x 50cc 
(50cc) 
1 x 100cc 
(100cc) 


































Figure 142 Filtered pressure for 5cc/s with 100cc volume for one long shot 
 
Table 20 Long single injection at 10cc/s A. Flowrate values B. Pressure values 
A 
10cc/s 
Flow rates ( / )L min  





1 x 50cc 
(50cc) 
1 x 100cc 
(100cc) 





































Pressure  mmHg  
upperP  lowerP  RPAP  LPAP  aorticP  
1 x 50cc 
(50cc) 
1 x 100cc 
(100cc) 



































Figure 144 Filtered pressure for 10cc/s with 100cc volume for one long shot 
 
Table 21 Long single injection at 15cc/s A. Flowrate values B. Pressure values 
A 
15cc/s 
Flow rates ( / )L min  





1 x 50cc 
(50cc) 

















1 x 150cc 
(10cc) 













Pressure  mmHg  
upperP  lowerP  RPAP  LPAP  aorticP  
1 x 50cc 
(50cc) 
1 x 100cc 
(100cc) 



































Figure 146 Filtered pressure for 15cc/s with 100cc volume for one long shot 
 
Table 22 Long single injection at 20cc/s A. Flowrate values B. Pressure values  
A 
20cc/s 
Flow rates ( / )L min  





1 x 50cc 
(50cc) 
1 x 100cc 
(100cc) 




































Pressure  mmHg  
upperP  lowerP  RPAP  LPAP  aorticP  
1 x 50cc 
(50cc) 
1 x 100cc 
(100cc) 


































Figure 148 Filtered pressure for 20cc/s with 100cc volume for one long shot 
 
4.2.3.2. Entrainment Quantification  
Once the experimental protocol has been completed, flow rates sampled at described 
locations are time-averaged. Entrainment is calculated from Equation 21  and reported for 
the whole parameter space explored in Table 23. Green values 
.
0entQ  represent cases for 
which entrainment was detected, and red values 
.
0entQ   are cases where the blockage 
occurred.  
One can observe how for either continuous or pulsed injections, varying the total volume 
injected has no significant influence on the entrainment rate across all injection rates. On 
the other hand, increasing injection rate results in a reduction in entrainment consistent 




2.6 mm used in this experiment, this outcome suggests that entrainment is strongly 
correlated to the co-flow velocity ratio (and flow rate ratio) and weakly correlated to the 
total injected volume. In addition, Table 24 offers significant insight on the differences 
between injection conditions (continuous vs. pulsed). In Table 24-A, the entrainment cutoff 









LQ . To better understand the degree of entrainment, the tabulated 
maximum values (for 
.
0.3injQ  ) can be normalized by the 
.
injQ . After averaging across the 












   for a pulsed 
injection . This stark contrast highlights a clear difference between injection conditions 
which emphasize the importance of ensuring proper physiological modeling: pulsatility 
cannot be overlooked. Conversely this opens the door for a discussion involving pulsatility 
modulation to enhance entrainment. Since, the shunt diameter is kept constant, an 
increasing flow rate indicated an increased co-flow velocity ratio ( jet backgroundV V ), it would 
sound counterintuitive to have increasingly positive results for a decreasing velocity ratio. 
However, results presented in the following section for the jet relaxation time will provide 
further insight in the jet dynamics and clarify this puzzling outcome. 
Table 23 Jet relaxation time [ s ] for various injection rates injQ and injection volumes injV for (A) 
continuous and (B) pulsed injections. Green values 0relt  and red values 0relt  . 
(A)  ?̇?𝑖𝑛𝑗 [𝐿/𝑚𝑖𝑛] 






















(B)  ?̇?𝑖𝑛𝑗 [𝐿/𝑚𝑖𝑛] 













Table 24 offers an overview of the calculated jet relaxation time 𝑡𝑟𝑒𝑙 for the same parameter 
space explored in the previous section. Green values ( 0relt  ) represent lack of potential 
fluid buildup and red values ( 0relt  ) would indicate a high likelihood of fluid buildup. 
Due to the choice of sampling rate in the experimental phase the following tabulated 
observations may show some inconsistency, nevertheless for most cases a trend can be 
perceived. 
In Table 23-A, aside from the data reported for 0.1injV  which displays an opposite 
tendency, for continuous injections it can be observed that varying the injected volume injV  
does not significantly alter relt . On the other hand, increasing 
.
injQ  appears to display 
decreasing trend with a maximum for 
.
0.6injQ  . This would indicate that for increasing 
injection flow rate, the fall-time tends towards the rise-time; suggesting that for increasing 
co-flow velocity ratio the flow field requires significantly more time to dissipate the jet 
effect. A similar trend can be seen for pulsed injections. Such an outcome is to be expected. 




entrainment quantifications where for lower co-flow velocity ratio enhanced entrainment 
is registered. This observations become even more relevant for the pulsed injection cases. 
Table 24 Jet relaxation time [ s ] for various injection rates injQ and injection volumes injV for (A) 
continuous and (B) pulsed injections . Green values 0relt  and red values 0relt  . 
(A)  ?̇?𝑖𝑛𝑗 [𝐿/𝑚𝑖𝑛] 



















(B)  ?̇?𝑖𝑛𝑗 [𝐿/𝑚𝑖𝑛] 













4.3. Uncertainty Analysis  
Table 25 provides the types of errors specified by the manufacturers of the pressure 
sensor. The uncertainty due to the different types of error is computed using the Type B 
estimate. 
Table 25 Error parameters for Pressure sensor 
Parameter Description  Mean 
Value 






Sensitivity - influence coefficient 
Pressure(P) :m Voltage(V) [calibration equation] 









Uncertainty due to error is computed using Equation (49) discussed in section 3.10.1 
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and Span 



























 var( . . . )x x y y z zu c c c      (55) 
 
Where u is the total uncertainty, xc , yc , zc  are sensitivity coefficients and x , y , z are 
uncertainty due to a errors in the system. There exists no correlation between error 
sources within the pressure sensor. The uncertainty model is re-written 
2 2 2 2 2 2. . .x x y y z zu c c c      
2 2 2(0.0638) (0.051) (0.051) 0.0963 Vu      
The pressure sensor's combined error is converted mmHg to compute the error values at 
different sections, thereby establishing the true pressure value. Figure 149 shows the 
mean IVC pressure values for the various MFL parameters tested. 
 










Overall, through this research work, the implementation of experimental methodologies 
has been demonstrated to quantify and qualify the detailed hemodynamics of two novel 
surgical techniques, i.e., HCSII and the self-powered Fontan circulation. These in-vitro 
investigations allowed us to determine the potential presence of any pathological flow 
fields and estimate the efficacy of tools implemented to improve patient care.   
A multiscale model of the HCSII circulation is designed and developed. In this study, the 
MFL experimentally quantifies the stented baffle deformation over periodic cardiac cycles. 
The in-situ observation of the stented baffle deformation shows that the stent placed in the 
PA conduit goes for a minimal deformation for each heart cycle. Fatigue analysis on this 
stent deformation proves that the stent will not fail under the pulsatile loading condition 
produced due to the systemic circulation at the MPA site. Hence the pulmonary artery will 
remain unobstructed. Experimental particle residence time analyses elucidate that there is 
a minimal chance for the occurrence of any pathological flow and the probability of 
thrombus formation in this reconstructed physiology is very low.  
Secondly, another multi-scale model of the Fontan circulation has been constructed. The 
MFL used in this study experimentally simulates the effect of the IJS implementation in 




combines the 0-D scale of the patient’s circulation in the LPM with a 3-D centerpiece 
physiological representative TCPC model. Various patient generic TCPC models and IJS 
prototypes have been developed using stereolithography technology. The outcome of these 
experimentations has successfully satisfied the hypothesis as established in the objective 
of the study. A parametric study on IJS nozzle diameter, IJS anastomosis angles, and PVR 
effect have been conducted in these experiments. The comparative study on the IJS nozzle 
shows that the 3mm nozzle is the most efficient for entraining the flow in the PAs. The IJS 
anastomosis angle study shows that the IJS nozzle can entrain better in the PAs as the angle 
becomes shallower. Finally, by incorporating the PVR effect along with the 3mm IJS 
nozzle, the desired pressure drop of 5mmHg is achieved. While conducting these 
experiments, as the IJS nozzles are introduced to the flow field, pulsatility in the PAs has 
been increased, and comparatively, high-frequency noise is introduced. This high-
frequency noise is filtered by conducting spectral analysis. Few benefits of the IJS include:  
 Increased Pulmonary flow Qp 
 Increased systemic oxygen  
 Lesser pathological flow in TCPC 
Thirdly, another in-vitro analysis is conducted to experimentally quantify the change in the 
hemodynamics of a sick Fontan while performing the PVR protocols as provided by our 
clinical collaborators from Arnold Palmer Hospital for Children.  The outcome of the PVR 
injection study is twofold. The preliminary in-vitro analyses show that PVR injections do 
not elevate the PA pressure beyond any critical threshold. For all long and short bursts of 
injections, no pathological flows have been observed in the systemic, pulmonary, and 




patient subsets. The entrainment study quantitatively shows that the degree of entrainment 
varies with the long and short burst of injections. Jet relaxation time provides a good insight 




6. Recommendations and Future Work 
This research has successfully demonstrated the capabilities of various types of in-
vitro setups that can be used to investigate and validate in-silico and in-vivo results. 
However, there are certain limitations to this study. Few of these limitations can be 
overcome in future work.  Both MFL setups do not have any feedback mechanism, which 
is especially important for conducting investigations like self-powered Fontan circulation. 
We aim to couple a fully automated Hardware in the Loop-based Harvard apparatus pump 
with the MFL loops in our future work. This modification will incorporate some amount 
of autoregulatory feedback mechanism in the MFL setups.  
In HCSII circulation research project, currently, only a particle diameter of 2mm 
has been injected. In the future, different size particles should be injected into the MPA 
conduit to complete the  PRT studies.  
The proof of concept study on Fontan will help us to proceed to more complex 
models. The 3-D phantoms should be made of a compliant material to validate the fluid-
structure interaction studies. Also, particle image velocimetry capabilities should be 
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1.1 Instrumentation wiring schematic  
 
 













1.2 Fontan hemodynamics  
1.2.1 2mm IJS  
 
 







1.2.2 4mm IJS 
 
 









1.2.3 3mm IJS at 45 degree 
 
 






1.2.4 3mm IJS at 90 degree 
 
 






1.2.5 PVR10  
 
 








1.3 PVR injection experiment 
1.3.1 Case 1: 5 cc/s short injection  
1.3.1.1 5 x 15cc injections (75cc total volume)  
 
 









1.3.1.2 10 x 10cc injections (100cc total volume)  
 
 








1.3.1.3 10 x 5cc injections (50cc total volume)  
 
 





1.3.2 Case 2: 10 cc/s short injection  
1.3.2.1 5 x 15cc injections (75cc total volume)  
 
 






1.3.2.2 10 x 10cc injections (100cc total volume)  
 
 







1.3.2.3 10 x 5cc injections (50cc total volume)  
 
 








1.3.3 Case 3: 15 cc/s short injection  
1.3.3.1 5 x 15cc injections (75cc total volume)  
 
 






1.3.3.2 10 x 10cc injections (100cc total volume) 
 
 





1.3.3.3 10 x 5cc injections (50cc total volume) 
 
 






1.3.4 Case 4: 20 cc/s short injection  
1.3.4.1 5 x 15cc injections (75cc total volume)  
 
 





1.3.4.2 10 x 10cc injections (100cc total volume)  
 
 






1.3.4.3 10 x 5cc injections (50cc total volume)  
 
 





1.3.5 Case 5: 5 cc/s long injection  
1.3.5.1 1 x 50cc injections (50cc total volume) 
 





1.3.5.2 1 x 150cc injections (150cc total volume) 
 
 






1.3.6 Case 6: 10 cc/s long injection  
1.3.6.1 1 x 50cc injections (50cc total volume) 
 
 





1.3.6.2 1 x 150cc injections (150cc total volume) 
 
 






1.3.7 Case 7: 15 cc/s long injection  
1.3.7.1 1 x 50cc injections (50cc total volume) 
 
 





1.3.7.2 1x 150cc injections (150cc total volume) 
 
 






1.3.8 Case 8: 20 cc/s long injection  
1.3.8.1 1 x 50cc injections (50cc total volume) 
 
 





1.3.8.2 1 x 150cc injections (150cc total volume) 
 
 
Figure 175 Filtered flowrate (U) and pressure (L) for 20cc/s with 150cc volume for one long shot 
